I. Studies on the Activation of Drosophila Phenol Oxidase. II. Studies On Serum Insulin in Normal Subjects and Diabetics by Seybold, William Davidson
PART I 
STUDIES ON THE ACTIVATION OF DROSOPHILA PHENOL OXIDASE 
PART II 
STUDIES ON SERUM INSULIN IN NORMAL SUBJECTS AND DIABETICS 
Thesis by 
William Davidson Seybold 
In Partial Fulfillment of the Requirements 
for the Degree of 
Doctor of Philosophy 
Cal1forn1a Institute of Technology 
Pasadena, California 
1972 
(Submitted May OS~ 1972 ) 
11 
This thesis is 
dedicated to my 
parents. 
iii 
ACKNOWLEDGEMENTS 
My life at Caltech has been enriched by interactions 
with a variety of individuals who have helped me with 
hints, encouragement, scientific advice and suggestions on 
how to enjoy life in Southern California. Although these 
individuals are too numerous to mention, the following 
deserve special thanks. 
Dr. H.K. Mitchell who was always ready to help and yet 
was also willing to stand back and let me learn by making 
my own mistakes. 
Dr. s. Gordon Ross for valuable discussions on the 
subject of diabetes and for providing serum samples from 
diabetic subjects. · I would also like to acknowledge the 
financial assistance of the s. Gordon Ross Foundation. 
Drs. David Sullivan and Alan Blumenthal whose work 
provided much of the background for the experiments 
reported here. 
Dr . Paul Meltzer who collaborated with me on the phenol 
oxidase project and whose scientific criticism was an 
invaluable help. 
My many and varied room-mates who provided a variety of 
memorable experiences over the years. 
Special thanks are due to my wife Tisa whose love and 
encouragement provided much needed inspiration for the 
iv 
completion of this work. 
The McCallum Foundation for financial assistance. 
v 
ABSTRACT 
PART I 
Phenol oxid.ase is the enzyme responsible for hardening 
and pigmentation of the insect cuticle. In Drosophila, 
phenol oxidase is a latent enzyme. Enzyme activity is 
produced by the interaction of a number of protein components. 
A minimal activation scheme consisting of six protein 
components, designated Pre S, S activator, S, P, P' and 
A1 , is described. , Quantitative assays have been developed 
for the S activator, S, P and pv proteins and these 
components have been partially purified. Experiments 
•1 describing the interactions of the six components have 
been conducted and a model for the activation of phenol 
oxidase in a minimal system is proposed.. Possible mechanisms 
of the reactions between the constituents of the activating 
system and potential regulatory mechanisms involved in 
phenol oxidase production and function are d.1scussed. 
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ABSTRACT 
Part II 
A method has been developed for the partial purification 
of insulin from human serum. A procedure for the deter-
mination of the electrophoretic mobility of serum insulin 
on polyacrylamide gels is described. An electrophoretic 
analysis of insulin isolated from a normal subject is 
reported and in addition to a major band, the existence of 
a number of minor bands of immunoreactive insulin 1s de-
scribed. A comparison of the electrophoretic patterns of 
insulin isolated from normal and d.iabetic subjects was 
carried out and indications that differences between them 
may occur are reportedo 
vii 
TABLE OF CONTENTS 
Title 
I STUDIES ON THE ACTIVATION OF 
II 
DROSOPHILA PHENOL OXIDASE ••••••••••• 1 
Introduction ••••••••••••••••••••••••••• 2 
Materials and Methods ••••••••••••••••• 18 
Results ••••••••••••••••••••••••••~•••• 29 
Discussion • • • e • e • • e e • e a • e e • • • e e • • • • • • e 
References • • 8 • • • • • • • • • • • • • • • • • • • • • • • • Q 
STUDIES ON SERUM INSUL:J:N IN 
NORMAL SUBJECTS AND DIABETICS • • • 
87 
99 
io2 
Introduction•••••••••••••••••••••••• 103 
Materials and Methods ••••••••••••••• 113 
Results • , , , • • • • • • • • • • • • • • • • • • • • • • • • .. 116 
Discussion • • • • • • • • • • ' • • 0 • • • • • • • 8 Q • 9 • 132 
References • • • • • • • • • • • • • • • • • • • • • • • • • • 135 
Abbreviations (Parts I and II) • .. • • • • • • • • 138 
-1-
PART I 
STUDIES ON THE ACTIVATION OF DROSOPHILA PHENOL OXIDASE 
-2-
INTRODUCTION 
Section 1. General. 
Drosophila has long been recognized as a valuable tool 
1n the study of genetics 1n eukaryotic organisms. Although 
the possibilities of Drosophila as a system for the study 
of development and . differentiation were realized long ago 
by Stern, Hadorn and others {5J), interest in the develop-
mental biology of Drosophila has increased in recent years. 
Phenol oxidase is a complex, developmentally controlled 
enzyme in Drosophila {JO, JJ, J4, J5, 40) and is a poten-
tially useful tool for the study of problems concerned w1th 
the developmental control of enzyme activity and with the 
control of cuticular biosynthesis. This thesis is .con-
cerned with a biochemical analysis of phenol oxidase as a 
prelude to studies of its developmental regulation. 
The comparative biochemistry of phenol oxidase has been 
extensively reviewed on several occasions (1, 2, J8, 54). 
Section 2. Reactions and Nomenclature. 
Phenol oxidase {o-diphenola o2 oxidoreductase, 
E.c.1.10.J.l) catalyzes the ortho hydroxylation of mono-
phenols and the production of ortho quinones from ortho 
diphenols. The enzyme bas been called tyrosinase, phenolase, 
phenolase complex, dopa oxidase, polyphenol oxidase. 
cresolase, and catecholase (2). 
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Section J. Function. 
A. Insects. 
Phenol oxidase is involved in pigmentation and 
hardening of the insect cuticle (36). This function is 
mediated through the production of quinones derived from 
the oxidation of phenolic compounds (37). The resultant 
highly reactive quinones can enter into polymerization 
reactions and also cross link polypeptide chains of cuticular 
proteins (J8). These reactions result in hardening and 
pigmentation of the integument (39). In addition to its 
enzymatic function in cuticular synthesis it has been 
proposed that phenol oxidase may also play a structural 
role in the formation of cuticle (40). 
Phenol ox1dase functions unrelated to cut1cular 
synthesis have also been proposed. These include wound 
healing (46) and defense against invading parasites (47). 
B. Plants. 
The phenol oxldase function which has received 
the most attention in plants is the browning reaction fol-
lowing injury. The suggestion has been made that this 
reaction is connected with wound healing and antibiosis 
(51). The enzyme has also been implicated in the b1osyn-
thes1s of 11gn1ns, tannins, alkaloids and flavono1d.s and in 
the hardening and browning Qf seed coats, spores and barks 
(38). 
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c. Vertebrates. 
Phenol oxidase is the enzyme responsible for 
melanizat1on in vertebrates (52). Melanins 1n vertebrates 
are found in specialized cells called melanocytes, 1n the 
form of granules with a well defined structure (41). 
Section 4. Latency. 
A. General. 
Phenol ox1dase 1s observed to occur in a latent 
form in many species. This may be partly due to problems 
of transport. Phenol ox1dases are often observed to occur 
in a highly aggregated insoluble state which may be neces-
sary ·for function. Transport of the enzyme to its site of 
action would be facilitated by deposition of soluble, lower 
molecular weight precursors followed by activation and 
aggregation in situ. Protection against the extremely 
reactive and often toxic quinones produced by phenol oxidase 
may also account for the maintenance of the enzyme in an 
inactive form when not required. 
B. Vertebrates. 
Only a few examples of latent phenol ox1dases 
h~ve been described 1n vertebrate systems. This may be 
partly due to difficulties involved in extracting phenol 
oxidases from the tightly organized melanin granules where 
phenol oxidase activity is located. 
A soluble precursor of phenol oxidase can be extracted 
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from the skin of the newt, Triturus cristatus. This enzyme 
can be activated by anionic detergents (3). 
There is a report on the activation of phenol ox1dase 
in extracts of Rana pipiens eggs (4). A variety of dena-
turing agents including chloroform vapor, urea, anionic 
detergents, and urethane result in the appearance of enzyme 
activity. A soluble phenol oxidase precursor has been 
extracted from the skin of adult Rana pipiens. The enzyme 
is activated by treatment with trypsin (5). 
There are few data bearing directly on the question of 
activation of latent phenol oxidases in the mouse. Work by 
Moyer (41), however, has suggested that elaboration of phenol 
oxidase activity in the melanin granules of mouse melanocytes 
may be the result of a co~lex aggregation of proteins. He 
studied the development of melanin granules and observed 
that granule development consists of the aggregation of sub-
units into fibers and the cross linking of these fibers to 
form a sheet-like matrix which contains phenol oxidase activ-
ity. The formation of the matrix is seen to coincide with 
the deposition of melanin at periodic intervals along the 
matrix. Alleles at three loci, B, C and P are seen to alter 
the sequence of development in a manner suggesting that they 
are the structural genes for different macromolecules con-
tained in the subunits. The suggestion is made that the 
subunit of the granule ls a complex aggregate of molecules 
containing phenol oxidase activitya 
.. 
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C. Fungi. 
Although considerable research has been done on 
fungal phenol oxidases there are few data concerning acti-
vation reactions. 
No phenol oxidase precursor has been isolated from 
Neurospora, however there 1s an observation of an increase 
in phenol ox1dase activity, exhibiting first order kinetics, 
in extracts of Neurospora (6). 
In fresh extracts of the ascomycete, Podospora anserina 
phenol oxidase exists in a latent form(?). Activation is 
observed on purification or heating. The latent and active 
forms of the enzyme have different electrophoret1c mob111ties 
but the same sedimentation constant. · 
D. Insects. 
1. General. 
Phenol ox1dase has been observed to occur in 
a latent form in all systems stud.led. In those systems in 
which the process has been well characterized, the activation 
seems to be quite similar. 
2. Melanoplus. 
A number of papers have been published by 
Bodine and co-workers describing the activation of phenol 
oxidase in eggs of the grasshopper Melanoplus d1fferential1s 
(89 9, 10, 11, 12, 13). No phenol oxidase activity ls 
observed in fresh extracts of Melanoplus eggs. Phenol 
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ox1dase activity appears 1n homogenates following a period 
of incubation at o0 c. If the extract is centrifuged prior 
to the appearance of enzyme however, the process of activa-
tion ls blocked and the proenzyme is obtained 1n a soluble, 
stable form. This proenzyme can be activated by mixing it 
with the 11p1d layer removed by centrifugation or by a 
variety of denaturing agents including heat, urea, anionic 
detergents, organic solvents, shaking and heavy metals. On 
the basis of these results Bodine suggested that the 1n vivo 
act1vat1on process involves a partial denaturat1on of the 
proenzyme. It ls d1ff1cult, however to rule out the poss1-
b111ty that a proteinaceous activating factor is involved. 
In most other insect systems which have been studied the 
presence of a protein activating factor seems to be indi-
cated. Evidence suggests that in several systems it is 
itself latent. It would seem possible that the failure to 
demonstrate a protein activating factor in this system can 
be attributed either to a failure to extract part of an 
apparently complex activating system or to the denaturation 
of some component of it. The activation by denaturing 
agents may.be an artefactual phenomenon. 
3. Tenebrio. 
Phenol oxidase in extracts of Tenebrio 
molitor last 1nstar larvae also exists as a soluble pro-
enzyme (14). The proenzyme can be maintained in a latent 
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form by centrifugation or chromatography on Sephadex G-25. 
An activating factor which is stable to heating at 100°c. 
is found in the centrifugal precipitate. The proenzyme 
was activated by 16 to 22 carbon fatty acids isolated from 
the larval integument. No evidence was found -for a protein 
activator but as in the case of the Melanoplus enzyme, 
negative evidence cannot be regarded as conclusive. 
4. Musca. 
A soluble proenzyme can be isolated from 
Musca vicina at all ages (15). Activation occurs with 
sigmoidal kinetics following a concentration dependent lag 
period.. Proenzyme has been prepared in a stable form from 
prepupae, which lack activating capacity. Activator free 
of proenzyme has been prepared by ammonium sulfate frac-
tionation of pupal extracts (16). In the course of kinetic 
experiments Ohn1shi has shown that an increase in activator 
concentration occurs during phenol oxidase activation 1n 
crude extracts (17). Ohnishi suggested that this fact 
supports an autocatalytic mechanism ,but the results can 
also be explained by assuming that the activator occurs in 
a latent form which undergoes an activation reaction. A 
Lineweaver-Burke plot of the kinetics of activation with 
proenzyme and activator suggest a simple enzyme substrate 
relationship (18). Sodium picryl sulfate, k-bromo~uccinimide 
and iodide block the activation by irreversible inhibition 
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of the activator. These compounds have no effect on the 
proenzyme. The activator is heat labile, non dialyzable 
and unstable to pH below 6 or above 9. The active enzyme 
tends to aggregate and can be removed from solution by 
centrifugation. 
5. Calliphora. 
Karlson and co-workers have conducted ex-
tensive investigations of Calliphora erythrocephala phenol 
oxidase. Fresh extracts are devoid of phenol ox1dase 
activity. Activity appears in extracts on incubation at 
o0 c. following a concentration dependent lag period. The 
activation process exhibits sigmoidal kinetics (19). The 
kinetics of activation have been analyzed at varying con-
centrations and were found not to fit well with the 
theoretical curves for an autocatalyt1c process. The sug-
gestiqn was made that the sigmoidal activation kinetics 
could be accounted for by assuming that the activator exists 
as a latent precursor. It has been reported that the acti-
vator, which 1s located in the integument and the proenzyme, 
isolated from the hemolymph have been purified (21). The 
criteria of purity however are not satisfactory. When 
purified activator and proenzyme are mixed, activation 
follows linear kinetics with no lag period.. The proenzyme 
can be activated by a-chymotryps1n and aminopeptidase (20). 
The suggestion is made that the natural activation process 
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invol ve s limited proteolysis. A conclusive demonstration 
of this hypothesis will have to await the demonstration 
that the natural activator can act in a proteolytic fashion 
on the proenzyme to produce active phenol oxidase. 
An interesting experiment in this system suggests that 
the synthesis of the activator is controlled by ecdysone, 
the moulting hormone (22). Destruction of the ring gland 
results in a sharp decline in activator concentration. 
Injection of ecdysone results in an increase in the concen-
tration of the activator to its normal level within 2 days. 
Ecdysone itself does not act on the proenzyme in vitro (23). 
Work in Calliphora stygia has shown the activator to 
be located in the integument in this species as well (24). 
Activator is found. in the .cuticular lining of the salivary 
duct but not in the salivary gland cells themselves. Act i -
vator isolated from Drosophila was found to activate the 
Calliphora proenzyme. 
6. Bombyx. 
Activation of phenol oxidase from the hemo-
lymph of Bombyx !!12.tl also occurs with sigmoid.al kinetics 
following a concentration dependent lag period (25). Ac-
tivation is accompanied by aggregation of the active en-
zyme. The activator, located primarily in the integument, 
and the proenzyme, found in the hemolymph, can be separated 
by ammonium sulfate fract1onationo When activator and pro-
enzyme are mixed, phenol oxidase activity is produced with 
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no lag per1od and. linear kinetics. The pH optimum of the 
activation process is around pH 6.o. The reaction is 1n-
h1b1ted at h1gh 1onic strength. The proenzyme can also be 
activated using a-chymotrypsin or sem1 alkaline protease 
of Aspergillus melleus, however the enzyme produced differs 
in several ways from the product of the natural activation 
system. The active enzyme is about half the molecular 
weight of the proenzyme and no aggregation occurs. The 
product of the artificial aotivatiori also has no monophenol 
oxidase activity and lacks stereospecificity in reactions 
with diphenols (26). In addition, less than 10% of the 
potential activity -of the proenzyme is released (26). The 
suggestion is made that the natural activation involves 
limited proteolysis, however no evidence has been presented 
linking the artif1c1al activation with the in vivo process. 
Activation proceeds in a s.imilar manner in the Chinese 
oak silkmoth, Antheraea pernyi (27). A latent enzyme 1s 
found in extracts of Antheraea and activation proceeds 1n 
a sigmoidal fashion. The activation reaction has two pH 
optima and the suggestion is made that the activation 
reaction occurs in at least two steps. An increase in ac-
tivator concentration with time is observed in the crude 
extract and the suggestion is made that the activator is 
formed from a precursor (28). It is also noted that if · 
the rate of the activation reaction varies linearly as a 
function of activator concentration, then the linear 
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f ormat ion of activator would be sufficient to account for 
the s gmoidal kinetics observed. 
Before proceeding to a discussion of phenol oxidase in 
Drosophila it is of interest to summarize the problem as 
observed in the variety of insect systems discussed. In all 
of the systems it was found that phenol oxidase was a latent 
activity, being absent in fresh homogenates. In most of the 
cases discussed it was concluded that the enzyme was formed 
by the action of a protein activator on a proenzyme. Kinetic 
analysis of activation suggested a potentially more complex 
situation and the possibility that the activator itself was 
latent was discussed. In fact however, the activating sys-
tem was not resolved in sufficient detail in any of the sys-
tems to draw any firm conclusions concerning the activation 
process. Without such resolution it is impossible to deter-
mine the number of components which might be involved in the 
production of phenol oxid.ase. Isolation of a fraction 
which causes the activation of a proenzyme is not sufficient 
grounds to claim that the fraction contains a single acti-
vating component. An understanding of the production of 
phenol oxidase must depend on a definition of the system at 
the component level. This would involve fractionation of 
the components involved prior to the onset of activation. 
The work of Mitchell, described below, on the fractionation 
of the components of the Drosophila system will provide a 
background for the work presented in this thesis. 
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7. Drosophila. 
Phenol oxidase has been known in Drosophila 
since the work of Graubard (29). Horowitz and Fling, 
working with adult Drosophila melanogaster showed that 
phenol oxidase activity is latent in fresh extracts and 
following a concentration dependent lag period, activity 
appears with sigmoidal kinetics (JO). The reaction kinetics 
fit the theoretical curve for an autocatalytic process and 
Horowitz proposed that a molecule of activator reacts with 
a molecule of proenzyme to produce a molecule of active 
enzyme and another molecule of activator. As in other sys-
tems, the active enzyme aggregates and can be removed from 
solution by centrifugation. 
Ohnishi (31) demonstrated that a similar situation 
occurs in the larvae of Drosophila viri1ise Fresh extracts 
contain no activity and activation occurs with sigmoidal 
kinetics. 
Lewis and Lewis (32) demonstrated that the presence of 
lipid affects the in vitro process of activation. 
Mitchell has investigated the activating system in 
detail. Ammonium sulfate fractionation and disc electro-
phoresis have been utilized to demonstrate the existence of 
at least five protein components, designated A1 , A2 , A3, S 
and P, which participate in the activation reaction. 
The A components can be visualized on disc electro-
phoresis gels which have been preincubated in S and P 
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followed by incubation in substrate. A1 produces an enzyme 
with mono- and diphenol oxidase activity while the A2 and A) 
components produce an enzyme with only diphenol oxidase 
activity. 
Using dissection techniques, S activity has been localized 
in the larval salivary gland (34). As noted above, similar 
work on the larger Call1phora stygia salivary gland has 
located activator in the cuticular lining of the salivary 
duct but not in the salivary gland cells themselves. The 
suggestion has been made that S plays a catalytic role 1n the 
formation of phenol oxidase since it influences activation 
time but not maximal activity. A procedure for the partial 
purification of S has been published (34). S activity has 
been shown to be absent in 4 to 8 hour prepupae, accounting 
for the apparent lack of phenol oxidase activation at this 
stage (35). It has been demonstrated. that S activity is 
latent (34), 
Section 5, Research Outline. 
The. work of Mitchell et al. has shown that the activation 
of phenol oxidase in extracts of Drosophila involves the 
complex interaction of a number of components. The objective 
of the work presented in this thesis was to define a minimal 
activation scheme and to determine the nature of the inter-
actions between the various components involved in such a 
scheme, It was clear at the outset that this would involve 
pur1f1cat1on of the components concerned, at least 
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to the extent that the various constituents of the system 
could be shown not to be cross contaminated with each other. 
The finding of methods for handling and studying the vari-
I 
ous substances involved depended on the development of 
quantitative assays specific for each component. 
The results presented in this thesis suggest that a 
complex series of reactions is involved in the activation. 
A model of phenol oxidase activation consistent with the 
work of Mitchell et al. and with the work presented here 
is shown in Figure 1, as a framework for sorting out the 
components of the system. In this scheme, 6 components are 
shown interacting in an orderly sequence of reactions to 
produce active enzyme. The first step 1n the sequence is 
the conversion of the precursor of s, Pre s, to s. Th i s 
reaction is catalyzed by a component designated the S 
activator. The S formed in this reaction then acts cata-
lytically on the P component to form P' which in turn 
reacts with A1 to produce phenol ox1dase. A2 and A3 are 
not observed to be necessary in this sequence but it is 
assumed that, in· addition to A1 , these components do par-
ticipate in the activation process in vivo and in crude 
extracts. 
This thesis is concerned with the purification of the 
components mentioned in the proposed reaction sequence and 
with an analysis of the reactions which they und.ergo. 
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Figure 1. A model of a m1n1mal system for the activation 
or phenol ox1dasee 
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Pre s S-oct i vat or ·S CD 
p s P' ® 
P' + A1 Phenol oxidose @. 
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.MATERIALS AND METHODS 
1. Drosophila Culture. 
Drosophila melanogaster Oregon R eggs were collected 
and cultured according to the mass culture technique of 
Mitchell and Mitchell (42). Animals were collected on the 
sixth day after egg laying when at least 90% had formed 
puparia. These animals are referred to as 24 hour pupae. 
The pupae were washed. and. dried on filter paper and then 
frozen in liquid nitrogen and stored at -?o0 c. In some 
experiments, 4 to 8 hour prepupae were used.. These were 
carefully staged. by taking advantage of the fact that an 
air bubble 1s secreted. 4 hours after pupar1um formation 
which causes animals at this age to float, Mixed larvae 
and prepupae were put in distilled water and. any floaters 
were discarded. The other animals were collected, dried 
and incubated at 25°c for three hours. They were again 
placed. in distilled water and the floaters were collected 
and. dried. on filter paper. The animals thus selected were 
inspected under a dissecting microscope and. asynchronous 
animals were discarded. The staged. animals were stored. 
frozen at -?0°c. 
2. Phenol Oxidase Assays. 
Phenol ox1dase was measured as described. by Mitchell 
(35). One unit of phenol oxidase in this assay is defined 
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as that amount for which theAOD475 mµ./10 minutes 1s equal 
to 1.0 • 
. 3. Temperature, 
Unless indicated otherwise all procedures were carried 
out at o to 4°c. 
4. Gel Filtration. 
Bio-Gel P series gels were prepared as recommended by 
the manufacturer (43). Columns were poured at exactly the 
same hydrostatic pressure they were to be run at, Fractions 
were collected volumetrically, 
5, Hydroxylapatite Chromatography, 
Bio-Gel HT was prepared exactly as recommended by the 
manufacturer (43). ma~teur pipets were used for one ml. 
columns. For larger bed volumes small glass columns were 
used, Glass wool was used. for a bed support. Pressure was 
applied to the columns using a rubber bulb. 
6. * Preparation of H. 
H is a 36-56% ammonium sulfate fraction used in. the 
assay of the S component. Four grams of 4 to 8 hour pre-
pupae were ground to a smooth paste 1n a mortar and pestle 
* Based on a procedure suggested by H.K. Mitchell. 
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with 2 g. of sand and 8 ml. of 0.1 M phosphate buffer pH 
6. 3. The paste was diluted. with 40 ml. of 0 .1 M phosphate 
pH 6.3 and centrifuged at 30,000 r.p.m. for 10 minutes in 
the Type 40 rotor of the Beckman model L ultracentrifuge .• 
The supernatant was filtered through nylon mesh and brought 
to J6% saturated (NH4 ) 2so4 by the addition of saturated 
(NH4)2so4 . The precipitate was removed by centrifugation 
at 25,000 r.p.m. for 25 minutes in the Type JO rotor. The 
supernatant was brought to 56% saturation and the pellet 
was collected by centrifugation at 25,000 r.p.m. for 25 
minutes in the Type 30 rotor. The pellet was dissolved in 
4 ml. of 0.02 M phosphate pH 6.3. The solution was desalted 
by passage over a 10 ml. Sephadex G-25 column. Four ml. 
were discarded and. 6 ml. were collected. The H was stored 
frozen in 250 ~lK aliquots at -10°c. 
7. Preparation of A1 • 
• 
Ten grams of 24 hour pupae were ground to a smooth 
paste 1n a mortar and pestle with 5 g. of sand and 20 ml . 
of 44% saturated (NH4) 2so4 • The paste was d1luted with 
80 ml. of 44% (NH4)2so4 and centrifuged at 25,000 r.p.m. in 
the Type JO rotor for 20 minutes. The supernatant was 
filtered through nylon mesh and brought to 56% saturation 
by the addition of a solution of saturated (NH4)2so4 . The 
precipitate was collected. by centrifugation at 25,000 r.p.m. 
for ~l minutes in the Type JO rotor. The pellet was 
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dissolved in 10 ml. of 0.01 M phosphate pH 6.7 and. the 
solution was brought to 44% saturated (NH4 ) 2so4 . The 
precipitate was removed by centrifugation at 25,000 r.p.m. 
for 20 minutes in the Type 30 rotor. The supernatant was 
brought to 56% CNH4 )2so4 and the precipitate was collected 
by centrifugation at 25,000 r.p.m. for 20 minutes. The 
pellet was dissolved in 2 ml. of 0.01 ~ phosphate pH 6.7 
and dialyzed overnight against 500 ml. of the same buffer. 
The A1 preparation was stored frozen at -10°c in 250 pl. 
aliquots. 
8. Preparation of Pre s. 
One gram of 4 to 8 hour prepupae was ground to a 
smooth paste in a mortar and pestle with 0.5 g. of sand 
and 2 ml. of 0.1 M phosphate pH 6.3. The paste was diluted 
with 8 ml. of 0.1 M phosphate pH 6.3 and centrifuged at 
J0,000 r.p.m. for 5 minutes in the Type 40 rotor. The 
supernatant was filtered. through nylon mesh and brought to 
36% saturated (NH4)2so4 by the addition of a saturated 
solution of (NH4)2so4 • The pellet was collected by 
centrifugation at 25,000 r.p.m. for 20 minutes in the 
TyJ)e JO rotor. The pellet was dissolved in 2 ml. of 0.01 M 
phosphate pH 6.7 and 250 Jll. aliquots were stored frozen 
at -10°c. 
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9. Preparation of S Activator. 
A. Ammonium Sulfate Fractionation. 
One gram of 24 hour pupae was ground to a smooth 
paste in a mortar and pestle with 0.5 g. of sand and 2 ml. 
of 0.1 M phosphate pH 6.3. The paste was diluted with 8 ml. 
of 0.1 M phosphate pH 6.3 and centrifuged for 5 minutes at 
30,000 r.p.m. in the Type 40 rotor. The supernatant was 
filtered through nylon mesh and brought to 36% saturated 
(NH4)2so4 • The precipitate was removed by centrifugation 
at 25,000 r.p.m. for 20 minutes in the Type 30 rotor. The 
supernatant was brought to 56% saturated (NH4)2so4 and the 
pellet was collected by centrifugation at 25,000 r.p.m. for 
20 minutes in the Type 30 rotor. The pellet was d.1ssolved 
in 1 ml. of 0.01 M phosphate pH 6.7. 
B. Hydroxylapatite Chromatography. 
S activator (200 pl.) 9 prepared through ammonium 
sulfate fractionation as described in part A was applied to 
a hydroxylapatite column with a 1 ml. bed volume equilibrated 
with 0.01 M phosphate pH 6.7. The column was eluted with 
a step g.radlent of increasing concentrations of phosphate 
buffer. Fractions (2 ml.) were collected and assayed for 
S activator (see Results, section 1B). The on280 mp. of 
the fractions was measured. 
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10. Preparation of s. 
A. Ammonium Sulfate Fractionation. 
Ten grams of 24 hour pupae were ground to a smooth 
paste in a mortar and. pestle with 5 g. of sand and 20· ml. 
of 35% saturated ( NH4) 2so4 • The paste was diluted. with 
105 ml. of 35% (NH4)2so4 . The homogenate was centrifuged 
for 30 minutes at 9,500 r.p.m. in the GSA rotor of the 
Servall centrifuge. The supernatant and lipid layer were 
discarded. The pellet was washed by resuspension in 125 ml. 
of 35% ( NH4) 2so4 and collected. by centrifugation at 9, 500 
r.p.m. in the GSA rotor for 30 minutes. The washing was 
repeated once. Following the second wash the pellet was 
extracted with 45 ml. of 0.01 M phosphate buffer pH 6.7 
and centrifuged at 25,000 r.p.m. for 5 minutes in the Type 
JO rotor of the Beckman model L ultracentrifuge. The 
supernatant was immediately brought to 35% saturation by 
the addition of saturated (NH4)2so4 and centrifuged at 
25,000 r.p.m. for 20 minutes in the Type 30 rotor. The 
pellet was dissolved in 5 ml. of 0.01 M phosphate pH 6.7 
and centrifuged at J0,000 r.p.m. for 15 minutes in the 
T'ype 40. 2 rotor. This supernatant is referred to as 
crude S. 
B. Hydroxylapatite Chromatography. 
Crude S (5 ml.) was prepared as described above 
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and applied to a 5 ml. hydroxylapatite column equilibrated 
with 0.01 M phosphate pH 6.7. The column was -eluted with 
10 ml. of 0.1 M phosphate pH 6.3 followed by 8 ml. of 
0.02 M phosphate pH 6.7. Fractions (2 ml.) were collected 
and the on280 mµ. was measured. Aliquots (25 µl.) were 
assayed for S activity and for P 1 activity (see Results, 
section 1, parts C and E). 
11. Preparation of P. 
A. Ammonium Sulfate Fractionation. 
Two grams of 4 to 8 hour prepupae were ground to 
a smooth paste in a mortar and pestle with 1 g. of sand 
and 4 ml. 0.1 M phosphate pH 6.3. The paste was diluted 
with 16 ml. of 0.1 ~ phosphate pH 6.3 and the homogenate 
was centrifuged at J0,000 r.p.m. for 5 minutes in the Type 
40 rotor. The supernatant was filtered through nylon mesh 
and brought to 35% saturated CNH4)2so4 • The precipitate 
was removed by centrifugation at 25,000 r.p.m. for 25 
minutes in the Type JO rotor. The supernatant was brought 
to 50% saturated (NH4)2so4 and the pellet was collected by 
centrifugation at 25,000 r.p.m. for 25 minutes. The pellet 
was then dissolved in J ml. of 0.01 M phosphate pH 6.7 • 
• B. Hydroxylapatite Chromatography. 
An ammonium sulfate fraction (J ml.) was prepared 
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as described in part A and immediately applied to a 5 ml. 
hydroxylapatite column equilibrated with 0.01 M phosphate 
pH 6.7. The column was eluted with 10 ml. of 0.05 M phos-
phate pH 6. 7 and. 10 ml. of O .1 M phosphate pH 6. 7. Frac-
tions (2 ml.) were collected and 25 µl. aliquots were 
assayed for P activity (see .Results, section 1D). The 
on280 mµ. was measured. 
c. Bio-Gel P-60 Chromatography. 
An ammonium sulfate fraction (3 ml.) was prepared 
as described in part A and applied to a 2.5 x 80 cm. P-60 
column. The column was eluted with 0.01 M phosphate pH 
S~T at a flow rate of 8.5 ml./hour. Fractions (4.5 ml.) 
were collected and 50 )ll. aliquots were assayed for P ac-
tivity. The on280 111 of the fractions was measured. m.,-. 
12. Preparation of P'. 
Two methods were used for the preparation of P 1 • In 
the first method pv was prepared by the reaction of par-
tially purified S and P ~nd in the second pv was isolated 
from a crude S preparation. 
" Method I. 
One ml. of P partially purified through ammonium 
sulfate fractionation and hydroxylapatite chromatography 
(Materials and Methods, section 11) was incubated with . 
-26-
o.4 ml. of S partially purified through ammonium sulfate 
fractionation and hydroxylapatite chromatography (Materials 
and Methods, section 10) for at least 90 minutes. 
Method II. 
A. Ammonium Sulfate Fractionation. 
An ammonium sulfate fraction was prepared 
from 10 g. of 24 hour pupae exactly as described in section 
lOA above. 
B. Bio-Gel P-60 Chromatography. 
An ammonium sulfate fraction (5 ml.), prepared 
as described in part A above, was applied to a 2.5 x 80 cmg 
column. The column was eluted with 0.01 M phosphate pH 6.7 
at a flow rate of 8.5 ml./hour and 4.5 ml. fractions were 
collected. Fractions were assayed for pt activity (Results, 
section lE) and the on280 Dl)l• was measured. Fractions 
containing P 1 activity were pooled and concentrated by 
ultraf1ltrat1on. 
c. Bio-Gel P-30 Chromatography. 
An ammonium sulfate fraction (2 ml.), pre-
-pared as described in part A above, was applied to a 
2.5 x 35 cm. P-30 column. Fractions (3 ml.) were collected 
and assayed for pt activity. The on280 mp. was measured. 
D. Hydroxylapatite Chromatography. 
The pooled and concentrated fractions (2 ml.) 
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of the P-60 column (part B) were applied to a hydroxylapat1te 
column with a 1 ml. bed volume, equilibrated with 0.01 M 
phosphate pH 6.7. The column was eluted with 3 ml. each 
of 0.02 M phosphate, 0.05 M phosphate and 0.1 M phosphate 
pH 6.7. Fractions (3 ml.) were collected and assayed for 
P' activity. 
13. Ultrafiltration. 
Samples were concentrated in an Amicon ultrafiltration 
apparatus using nitrogen pressure at 45 p.s.1. A PM-10 
membrane was used. 
· 14. Protein Determination. 
Protein concentrations were measured by the method of 
Lowry et!:!• (45). Bovine serum albumin was used as a 
.standard. 
15. Sucrose Gradient Centrifugation. 
Sucrose velocity gradients were run using a modif 1cation 
of the method of Martin and Ames (44). Linear sucrose 
gradients were prepared in Lucite mixing chambers. Gradi-
ents were made from 5% and 20% (w/v) sucrose in 0,01 M 
phosphate pH 6.7. These were run in the Beckman L2-65 
centrifuge for 16 hours at PO~MMM g (max.) in the Type SW 
39 rotor. Fractions were collected by puncturing the 
bottoms of the tubes and were assayed for A1 and phenol 
-28-
oxidase activity. 
16. Reagents and Buffers. 
All reagents were reagent grade. Bovine serum albumin 
was obtained from Sigma Chemical Co. 
Saturated ammonium sulfate solutions were prepared in 
0.01 ~ phosphate pH 6.7 with no adjustment of the final pH. 
Phosphate buffers were a mixture of sodium and potassium 
salts. 
-29-
RESULTS 
Section 1. Assays of Components. 
A. General. 
In order to devise methods for handling and 
purification of the various components involved in the 
activation of Drosophila phenol oxidase, it was necessary 
to develop quantitative assays for the components. An assay 
for A1 has been described elsewhere (2). Assays have been 
developed for S activator, S, P and P 1 • 
B. S Activator Assay. 
The S activator is the component which catalyzes 
the conversion of the precursor of S, Pre S, to s. s acti-
vator was assayed for by incubating an aliquot of the un-
known (1 µl. to 50 µl.) with 50 pl. of Pre S (Materials 
and Methods, section 8) in a total volume of 100 pl. for 
60 minutes. The mixture was then assayed for S activity 
(Results, section 1C). A standard. curve for this assay 
1s shown 1n Figure 2. The assay appears to be fairly 
linear up to about 4.5 units of activity. 
c. S Assay. 
S is the component which catalyzes the conversion 
of P to P 1 • S activity was assayed for by the use of a 
slight modification of a method described by Mitchell {J4). 
An aliquot of the unknown (1 ~lK to 100 µl.) was incubated 
-30-
Figure 2, S activator assay. The S activator preparation 
was a 35-56% ammonium sulfate fraction from 24 
hour pupae prepared as described in Materials 
and Methods, section 9. The ammonium sulfate 
pellet was dissolved in 5 ml. of buffer per 
gram of starting material. A series of dilutions 
was prepared and assayed for S activator as 
described. 1n the text. The abc1ssa represents 
the volume in µl, of S activator in the 1ncu-
bat1on m1xturee 
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with 25 µl. of H, a 35-56% ammonium sulfate fraction (see 
Materials and Methods, section 6), in a total volume of 
125 µl. for 20 minutes. The phenol oxidase activity in the 
mixture was then measured. A standard. curve for the assay 
is shown in Figure 3. The curve is linear over about a 5 
fold range of S concentration. Since the assay curve in-
tersects the abcissa at a significant S concentration, 
caution must be observed when working with dilute solutions 
of s. For example, two fold dilution of a sample which can 
easily be assayed may bring 1t out of the useful range of 
the assay. A unit of S activity is defined as the amount 
of S which will produce one unit of phenol oxidase activity 
in the assay. This assay is also sensitive to P' and is 
therefore only quantitative in the absence of P'. 
D. P Assay. 
The P component is the precursor of P 1 • P was 
assayed for by incubating an aliquot of the unknown (1 µl. 
to 75 µl.) with 25 µl. of S (prepared through ammonium 
sulfate fractionation and hydroxylapatite chromatography, 
Materials and Methods, section 10, A and B) in a total 
volume of 100 Jll. for 60 minutes. An aliquot (25 µl.) of 
A1 (Materials and Methodse section 7) was then added to the 
incubation mixture and the phenol oxidase produced was 
measured 20 minutes later. A unit of P activity is defined 
as that amount of P which will produce one unit of phenol 
oxidase activity in the P assay. A standard curve for the 
-33-
Figure 3. Standard curve for the S assay. The S was 
prepared. as described in Materials and Methods, 
section 10. A series of dilutions of the S was 
prepared and assayed for S activity as described 
in the texte The abcissa represents the volume 
in Jll. of S in the 1ncubat ion mixture .• 
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assay is shown in Figure 4. The assay is linear up to 
about 4 units of activity and is sensitive to changes 1n P 
over a wide concentration range. 
E. pt Assay. 
pt is the component formed by the action of S on 
P. It reacts with A1 to produce phenol oxidase. P' was 
assayed for by incubating an aliquot of the unknown (1 µl. 
to 100 pl.) with 25 pl. of A1 (Materials and Methods, sec-
tion 7) in a total volume of 125 pl. for 20 minutes. The 
mixture was then assayed for phenol oxidase activity. A 
unit of P' activity is defined as the amount of pt re-
quired to produce one unit of phenol oxidase activity in 
this assay. A standard curve for the assay is shown in 
Figure 5. The assay is sensitive to changes - in P' concen-
tration over a wide range. The curve deviates strongly 
from linearity at high concentrations of P' but is fairly 
linear in the range of 0 to 2.5 units. 
Section 2. Purification and Characterization of the 
Components. 
A. General. 
It was clear that elucidation of the complex 
series of reactions concerned with phenol oxidase activation 
would involve purification of the components involved. A • 
primary problem in the handling of phenol oxidase components 
is the prevention of phenol oxidase activation in extracts. 
-36-
Figure 4. Standard curve for the P assay. The P protein 
was prepared from 4 to 8 hour prepupae and 
partially purified. over hydroxylapatite as 
described in Materials and. Methods, section 11. 
A series of dilutions was prepared and. assayed 
for P activity as described in the texta The 
abc1ssa represents the volume in pla of P in the 
incubation mixturee 
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Figure 5. pt assay. pt was prepared as described in 
Materials and Methods, section 12, Method I. 
Dilutions of the pv were made and assayed. as 
described in the text. The abc1ssa gives the 
volume of pt 1n µl. present 1n the incubation 
mixture. 
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Even small amounts of phenol oxidase activity can result 
in melanization and loss of component activity. Isolation 
of Pre S and P poses a special problem since these compo-
nents have a strong tendency to convert to S and P' respec-
tively. Mention is made in the sections devoted to each 
component of the methods used to prevent activation. This 
generally involved separation of the components before 
activation could occur, usually by means of ammonium 
sulfate fractionation. Use was often made of 4 to 8 hour 
prepupae since this stage animal lacks S activator activity. 
This results in the blockage of the conversion of Pre S to 
S and consequently of the activation of phenol oxidase (see 
section JA). 
B. S Activator Component. 
1. Ammonium Sulfate Fractionation. 
S activator was isolated from a 35-56% 
CNH4) 2so4 fraction so that the preparation would not be 
contaminated with Pre S which is found primarily in the 
0-35% (NH4)2so4 fraction. S activator is also present in 
the O-J5% {NH4)2so4 fraction, howeverj since the Pre S in 
this fraction is converted to S without the addition of any 
other fractions. 
2. Hydroxylapatite Chromatography. 
S activator was partially purified by chro-
matography on hydroxylapatite. The behavior of S activator 
-41-
on this column is seen in Figure 6. One useful aspect of 
this fractionation is that the S activator 1s separated 
from A1 and _A2 which stick much more tightly to this column 
than the S activator (2). 
c. Pre S Component. 
1. Ammonium Sulfate Fractionation. 
Pre s was prepared as a O-J5% (NH4 ) 2so4 
· fraction from 4 to 8 hour prepupae. This stage animal lacks 
I the S activator (see section JA) and as a result Pre S from 
this stage is relatively stable. Attempts have been made 
to separate Pre S and the S activator in other stage animals 
using a variety of techniques but these have not been 
successful. Attempts to inhibit reversibly the activation 
of Pre B in solution have also been unsuccessful. 
D. S Component. 
1. Ammonium Sulfate Fractionation. 
In order to prevent phenol oxidase activation, 
a 0-35% (NH4)2so4 fraction was prepared by grinding 24 hour 
pupae directly in 35% (NH4)2so4 • This blocks activation 
since the Pre S activity is precipitated at th1s concentra-
tion, while the bulk of the A component activity remains in 
solution (JJ). This also prevents the conversion of Pre S 
to S until the pellet is dissolvede It was found necessary 
to wash the pellet by resuspending it in 35% (NH4)2so4 and 
then to extract it with buffer and reprecipitate the Pre S 
-42-
Figure 6. Hydroxylapat1te chromatography of S activator. 
The S activator preparation was a 35-56% 
ammonium sulfate fraction from 24 hour pupae 
prepared as described in Materials and Methods, 
section 9. 200 pl. of the preparation was 
applied to a one ml. hydroxylapatite column 
equilibrated with .01 M phosphate pH 6.7. The 
column was eluted with a step gradient, 2 ml. 
each of 0.02 ~D 0.04 M, 0.08 ~K 0.1 M and Oe2 M 
phosphate pH 6.7. Aliquots (50 µl. ) of the 
fractions were assayed for S activator and the 
on280 mp. was measured. 
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activity by bringing the (NH4) 2so4 concentration back to 
35%. This step was necessary to free the pellet of resid-
ual A components. If this was not done, phenol oxidase 
activation was observed when the pellet was diss~lvedK 
When the pellet was finally dissolved it was allowed. to sit 
in the cold for at least 3 hours to allow complete conver-
sion of the Pre S to s. This fraction was found to contain 
both Sand also P'• the component which is produced by the 
action of S on P. The 10 g. of starting material contained 
approximately 1500 mg. of soluble protein. Approximately 
25 mg. of protein were recovered in the crude S fraction. 
2. Hydroxylapatite Chromatography. 
Further fractionation was required to sepa-
rate the S and P 1 activities. Chromatography on hydroxyla-
patite was used for this purpose and the results of such an 
experiment are shown in Figure 7. The S activity was sig-
nificantly retarded on the column with respect to the P' 
activity and although a complete separation was not obtained 
it was possible to obtain an S fraction free of pt by pool-
ing tubes from the trailing edge of the peak. This fraction 
did not react with A1 over a wide concentration range and 
was therefore considered free of pt which does react with 
A1 • The absence of pt also indicated the absence of P 
since P is rapidl7 converted into P' in the presence of S 
(see section JB), A1 was also considered to be absent 
-45-
Figure 7. Hydroxylapatite chromatography of crude s. The 
sample was 5 ml. of crude S prepared from 10 g. 
of 24 hour pupae as described in Materials and 
Methods, section 10. The column was eluted 
with a step gradient of phosphate buffer. Frac-
• 
tions 1 to 5 were eluted with 0.1 M phosphate 
pH 6.3. Fractions 6 to 9 were eluted with 
0.02 M phosphate pH 6.7. 2 ml. fractions were 
collected. 25 pl. aliquots were assayed for 
either S or pv with H or A1 respectively. 
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from the preparation since no phenol oxidase activity was 
produced when P' was added to the fraction. If A1 had been 
present it would have reacted with the pt to produce phenol 
oxidase {see section JC). The specific activity of S pre-
pared in this manner was 1.0,000 units/mg. The starting 
material contained 25 mg. of protein and 250 µg. were re-
covered in the S fraction. Yields or fold. purification 
cannot be calculated for either this fractionation or the 
previous one since the presence of pt interferes with the 
quantitative assay for the S component. 
E. P Component. 
1. General .. 
A major difficulty in the preparation of the 
P component was the prevention of its conversion to Pi by 
s. ,For this reason 4 to 8 hour prepupae were used in the 
preparation of P since the lack of S activator activity in 
these animals blocks the production of S and hence the 
conversion of P to P'. 
2. Ammonium Sulfate Fractionation. 
P was prepared as a )6-50% fraction from 4 
to 8 hour prepupae.. It proved to be relatively stable in 
this form but trace amounts of S in the preparation some-
times caused the production of pi on prolonged standing 
(24 hours). 
-48-
). Hydroxylapatite Chromatography. 
In order to separate P from any trace amounts 
of S and also from A components present in the 36-50% frac-
tion, this fraction was applied to a hyd.roxylapatite column 
immediately on resuspension of the 36-50% pellet. The 
elution behavior of P on this column is shown in Figure 8. 
The yield and fold purification in this step are shown in 
Table 1. The P activity was approximately 12 fold. purified 
over the ammonium sulfate fraction. The P prepared in this 
manner was considered to be free of S activity since no 
conversion to P' was observed on prolonged incubation ( 24 
hours). The preparation was also considered to be free of 
A1 since no phenol oxidase was produced on addition of P' 
which would have reacted with ariy A1 present to produce 
phenol oxidasee 
4. Bio-Gel P-60 Chromatography. 
P which had been prepared through ammon i um 
sulfate fractionation was chromatographed. on a P-60 column . 
The results are shown in Figure 9. The bulk of the P ac-
tivity is excluded on this column. The tail on the P peak 
is believed to be due to P' contaminating the preparation. 
This column is of no particular value in the purification 
of P but it does suggest that the minimum molecular weight 
of P is 60,000 daltons. This result is of interest in 
discussing possible mechanisms of the activation reaction. 
-49-
Figure 8. Hydroxylapatite chromatography of P. The 
sample was 3 ml. of a 35-50% ammonium sulfate 
fraction prepared from 2 g. of 4 to 8 hour pre-
pupae as described in Materials and Methods, 
section 11. The column had a 5 ml. bed. volume 
and was equilibrated with 0.01 M phosphate 
pH 6.7. The column was eluted. with a step 
gradient and 2 ml. fractions were collected. 
Fractions 1 to 5 were eluted with 0.05 M phos-
phate pH 6.7. Fractions 6 to 10 were eluted. 
with 0.1 M pho~phate pH 6.7. The on280 mµ. was 
measured and 25 µl. aliquots were assayed for 
P activity. 
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Table 1. 
Partial Purification of P. 
Protein Activity Specific Activity Yield 
Fraction (mg•) E_unKi_t_~~ (unitsLmg.). L 
I 
Ammonium sulfate 48 1200 25 '-" 
-
~ 
I 
Hydroxylapatite J 960 320 80 
-52-
Figure 9. Bio-Gel P-60 chromatography of P. The starting 
sample was J ml. of a 35-50% ammonium sulfate 
fraction prepared from 2 g. of 4 to 8 hour pre-
pupae as described in Materials and Methods, 
section 11. The column was 2.5 x 80 cm. The 
elution buffer was 0.01 M phosphate pH 6.7. The 
flow rate was 8.5 ml. per hour. 4.5 ml. fractions 
were collected. The on280 mp. was monitored and 
50 µ1. aliquots were assayed for P activity. 
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F. pt Component. 
1. Ammonium Sulfate Fractionation. 
The primary problem in the preparation of P' 
was to ensure its separation from the A components before 
phenol ox1dase activation could occur. Since the crude S 
preparation (described in section 2D part 1 above) contained 
large quantities of pt and no A1 the same ammonium &ulfate 
fractionation was used for the preparation of P•. The 
specific activity of pt in this fraction is shown in Table 
2. 
2. Bio-Gel P-60 Chromatography. 
pt prepared through ammonium sulfate frac-
tionation was chromatographed on a Bio-Gel P-60 column. 
The results are shown in Figure 10. The P' activity was 
separated from the bulk of the protein eluting from this 
column. Table 2 shows the fold pur1ficat1on and yields 
for this step. The Kav. of 0.35 indicates s molecular 
weigh~ of about 30,000 daltons (4)). 
\ 
3. Bio-Gel P-30 Chromatography. 
Gel filtration on P-30 has not been used in 
an integrated purification scheme for P 1 but it is a 
potentially useful step. P' was prepared through ammonium 
• 
sulfate fractionation and applied to a P-JO column. The 
results are shown in Figure 11. pt was slightly included 
-55-
Figure 10. Bio-Gel P-60 chromatography of P'. The sample 
was 5 ml. of P 1 prepared through ammonium sulfate 
fractionation as described in Materials and. 
Methods, section 12, Method IIA • . The column 
• 
was 2.5 x 80 cm. and was eluted with 0.01 ~ 
phosphate pH 6.7 at a flow rate of 8.5 ml./hour. 
Fractions (4.5 ml.) were collected and 100 pl. 
aliquots were assayed for P' activity. The 
on280 mp. was measured • 
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> 
Figure 11. Bio-Gel P-30 chromatography of P'. The sample 
• 
was 2 ml. of P' prepared as described in 
Materials and Methods, section 12, Method IIA. 
The column was 2.5 x 35 cm. Fractions (3 ml.) 
were collected and 100 µ1. aliquots were 
assayed for P 1 activity. The on280 mp. of the 
fractions was measured • 
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with a Kav. of 0.15. This again would indicate a molecular 
weight in the neighborhood of 30,000 d.altons (43). 
4. Hydroxylapatite Chromatography. 
P' which had been purified. through ammonium 
sulfate fractionation and P-60 chromatography was chroma-
tographed on a hyd.roxylapatite column. The percentage 
yields, fold purification and the specific activity of the 
eluted P' are shown in Table 2. 
G. A1 Component. 
1. Ammonium Sulfate Fractionation. 
A1 has been purified to homogeneity (2). The 
purification is a time consuming task however and for this 
reason an ammonium sulfate fractionation scheme was devised 
to prepare A1 which was suitable for use 1n the P and P' 
assays. Experiments demonstrating the su1tabil1ty of A1 
prepared in this way are summarized in Table ). The lack 
of reaction with S ind.icates the absence of P in the prep-
aration. 
Section 3. Reactions of the Components. 
A. Reaction of Pre S and S Activator. 
The existence of a Pre S - S activator system was 
suggested following Mitchell's observation that S activity 
1s latent and appears in homogenates on incubation at 
Table 2. 
Partial Purification of P'. 
Specific Fold 
Protein Activity Activity Yield 'f, Purification 
Fraction (mg.) (units) {uni tsLmg.} Step Total Step Total I 
°' 0 I 
Ammonium 
sulfate 27 1600 59 
P-60 1 560 560 35 35 9.5 9.5 
Hydroxyl-
apatite 0.05 210 4,200 37 13 7.5 71 
Table 3. 
Reactions of Partially Purified A1 With s. 
Phenol 
S Fraction A1 Fraction Buff er Oxidase 
Reaction Vol. (pl.) ~ Vol. (pl.) ~ _____rr~1 (units) 
1. 25 Purif 1ed1 25 Al 1 75 0 I 
°' 4 ..... 2o 25 Purified 25 H - 75 9.5 I 
3. 25 2 Crud.e- 25 Al 75 9.5 
4. 0 
-
100 Al 25 0.15 
5. 0 ~ 25 Al 100 0 
!Materials and Methods, section lOB 
2 
-Materials and Methods, section lOA 
1Materials and Methods, section 7 
4 
-Materials and. Methods, section 6 
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o0 c. (35). The results of an experiment confirming this 
observation are shown in Figure 12. 
The hypothesis that a two component system was neces-
sary for the production of S activity was confirm~d by 
mixing experiments using extracts of 4 to 8 hour prepupae 
and 24 hour pupae. Mitchell had previously made the 
observation that S activity was lacking in extracts of 
4 to 8 hour prepupae(35) and he -made the suggestion that 
this lack occurred because the precursor of S was not 
converted into S in these animals. This was confirmed by 
the results of the experiment described in Figure 1J. A 
0-35.% (NH4) 2so4 fraction from 4 to 8 hour prepupae was 
mixed with a 35-56.% fraction from 24 hour pupae and the 
appearance of S activity was observed in the homogenate. 
This experiment showed that potential S activity (Pre S) 
does exist in 4 to 8 hour prepupae and that there is a 
substance (S activator) in 24 hour pupae which can cause 
the conversion of this potential activity into active s. 
B. Reaction of S and P. 
1. General. 
Previous experiments had suggested the pos-
sibility that S and P react to form a product, which was 
named P', which 1n turn reacts with A1 to produce phenol 
oxidase. A series of mixing experiments using variable 
concentrations of S and P incubated. together for a variable 
-63-
Figure 12. Activation of s. Crude S was prepared as 
described in Materials and Methods, section 
10A. 25 )ll. aliquots were withdrawn at vary-
ing times following resuspension of the 
ammonium sulfate pellet and assayed for S acti-
vity. The abcissa represents time following 
resuspension of the pellet. 
-64-
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Figure 13. Activation of Pre S with a 35-56% ammonium 
sulfate fraction from 24 hour pupae. A 0-35% 
(NH4 ) 2so4 fraction from 4 to 8 hour prepupae 
and a 35-56% (NH4 ) 2so4 fraction from 24 hour 
pupae were prepared as d.escribed in Materials 
and Methods, sections 8 and 9. A 111 mixture 
of the two fractions was made and 25 pl. ali-
quots were withdrawn and assayed for S activity 
at varying times. In addition, the 0-35% and 
35-56% fractions were each diluted. 11 l with 
buffer and aliquots were withdrawn at varying 
times for the assay of S activity. The abcissa 
represents time following the mixing of the two 
fractionse The closed circles represent the mix-
ture of the two fractions, the open circles 
represent the 0-35% fraction alone and the 
triangles represent the 35-56% fraction. 
I 
I 
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time were conducted in an attempt to elucidate the nature 
of this reaction. The S used in the following experiments 
was prepared as described in Materials and Methods, section 
10 and the P was prepared as d.escribed in section 11, parts 
A and B. 
2. Excess S and . Variable P. 
In order to determine whether P can be 
limiting 1n low concentrations in the S and P reaction, 
experiments were conducted using high constant concentrat-
ions of S and low variable concentrations of P. A series 
of incubation mixtures were set up, each containing a high 
constant concentration of s. Variable concentrations of P 
were added to each tube and aliquots were withdrawn at 
varying times and assayed for P' activity with A1 • The 
results of such an experiment are shown in Figure 14. This 
experiment confirmed the observation that S and P react to 
form P 9 activity. This experiment also shows that P can 
become limiting in the reaction. After 20 minutes at high 
P concentrations and 40 minutes at lower concentrations~ no 
further increase of P' activity occurred and the final levels 
of activity reached were dependent on the concentration of 
P. In ord.er to show that P was in fact limiting when the 
curve levelled off, a mixture of excess S and low P was 
allowed to react to equilibrium, following which additional 
P was ad.d.ed. and. indeed. additional P' activity was produced. 
-68-
Figure 14. P concentration curves. P, S and. A1 were 
prepared as described in the text. 
Curve 11 each point represents 5 µl. of P 
incubated with 25 µl. of S in a total volume of 
100 ul. for the time indicated on the abcissa. 
Following this time 25 µl. of A1 were added. for 
20 minutes and the phenol oxidase in the incu-
bation mixture was assayed. 
Curves 2 to 5 represent the same experiment 
using 10 µl., 25 µl., 50 µ1., and 75 µ 1 . of P per 
point, respectively .. 
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The results of this experiment are summarized in Figure 15. 
3. Excess P and Variable s. 
In order to determine whether S can be limit-
ing in low concentrations in the S and P reaction, experi-
ments were cond.ucted using high constant concentrations of 
P and low variable concentrations of s. A series of incu-
bation mixtures were set up, each containing a high constant 
concentration of P. Variable concentrations of S were 
added to each tube and aliquots were withd.rawn at vary1n~ 
times and assayed for pt activity by incubation with A1 • 
The results of such an experiment are shown in Figure 16. 
This experiment indicated that, 1n contrast to P, there was 
no evidence that S could become limiting in the reaction. 
The highest concentration of S did level off but this was 
due to limiting A1 in the pt assay. With the lower concen-
trations of S, pt activity continued. to increase, even 
following 90 minutes of incubation. In contrast , even the 
lowest concentrations of P reached equilibrium in 40 min-
utes. It would. thus appear that S acts in a catalytic 
fashion on P to produce pt. The results of this experiment 
also suggested an alternative assay procedure for the S 
component. It appeared that the amount of pt formed. at 60 
minutes in an incubation mixture containing excess P and 
variable concentrations of S was proportional to the S con-
centration. The results of an experiment confirming this 
-71-
Figure 15. Limiting nature of P in the P plus S reaction. 
P, S and A1 were prepared as described in the 
text. 
1. Closed circles • . Each point represents 
10 µl. of P and 25 µl. of S in 100 µl. total 
volume incubated for the time indicated on the 
abcissa followed by a 20 minute incubation with 
25 µ1. of A1 and an assay of the phenol oxidase 
produced. At the arrow 50 µl. of additional P 
was added. 
2e Open circles. A parallel experiment 
in which no P was added. 
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Figure 16. S concentration curves. P. S and A1 were pre-
pared as described in the text. 
Curve ls each po1n~ represents 5 µl. of S 
incubated with 75 µl. of P in a total volume of 
100 µl. for the time indicated on the abcissa. 
Following this time 25 pl. of A1 were added for 
20 minutes and the phenol oxidase in the incu-
bation mixture was assayed. 
Curves 2, 3 and 4 represent the same expe-
riment using 10 µl., 15 µl. and 25 pl. of S per 
point respectively. 
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observation are shown in Figure 17. This assay is fairly 
linear in the range from 1 to 4 units and 1s sensitive to 
changes 1n S concentration over a wider range than the H 
assay (see Results, section 1C). 
c. Reaction of P' and A1 • 
1. General 
Previous experiments had indicated that P' 
and A1 react to produce phenol oxidase. In an attempt to 
elucidate the nature of this reaction, a series of mixing 
experiments were conducted using variable concentrations 
of P' and A1 • Unless indicated otherwise the P
1 used in 
the following experiments was prepared as described in 
Materials and Methods, section 12, Method I and the A1 was 
prepared as described 1n section 7. 
2. Excess A1 and Variable P'. 
In an attempt to determine the effects of 
variations in pt concentrations on the rate of the reaction 
·and on the final levels of activity produced, experiments 
were conducted using high constant concentrations of A1 and 
variable concentrations of P'. A series of incubation mix-
tures were set up, each containing a high constant concen-
tration of A1 • Variable concentrations of pt were added to 
the tubes and aliquots were withdrawn at varying times and 
assayed for phenol oxidase activity. The results of such 
an experiment are shown 1n Figure 18. The reaction of P' 
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Figure 17. Alternative assay for s. S was prepared as 
described in Materials and Methods, section 10. 
Aliquots (5-50 µl.) of S were incubated with 
50 µl. of P (Materials and Methods, section 11 ) 
for 60 minutes. A1 (25 µl., Material s and 
Methods, section 7) was added and the phenol 
oxidase activity was measured 20 minutes l ater . 
The abcissa represents the vol ume i n p l Q of the 
S in the incubation m1xturee 
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Figure 18. P' concentration curve. P' and A1 were pre-
pared as described in the text. 
Curve 11 each point represents 10 µl. of 
P' incubated with 25 pl. of crude A1 in a total 
volume of 100 µl. for the time indicated on the 
abcissa followed by a phenol oxidase assay. 
Curves 2 to 5 represent the same experi-
ment using 20 ~lKI JO µl., 50 µl. and 75 µle of 
P 1 per point respect1velye 
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with A1 occurred quite rapidly, reaching completion in 5 
minutes or less at the higher concentrations and in 15 
minutes at the lower concentrations. A point of considerable 
interest was the 11m1t1ng nature of P' in the reaction. In 
order to show that P' was in fact limiting when the curve 
levelled off, a mixture of excess A1 and low P' (prepared 
as described in Materials and Methods, section 12, Method II 
part B) was reacted to equilibrium. Additional P' was 
added and. indeed an increase in phenol ox1dase produced was 
seen. Additions of either S or P had no effect. The results 
of th1s experiment are summarized. 1n Figure 19. 
3. Excess P' and Variable A1 • 
In ord.er to determine the effects of variable 
A1 concentrations on the final levels of activity reached in 
the P' and A1 reaction, experiments were conducted using 
high constant concentrations of P' and variable concentra-
tions of A1 • A series of incubation mixtures were set up, 
each containing a high constant concentration of P'. Var-
iable concentrations of A1 were ad.ded. to each tube and. 
aliquots were withdrawn at varying times and. assayed for 
phenol oxidase activity. The results of such an experiment 
are shown in Figure 20. As expected the final level of 
phenol oxidase produced was d.ependent on the oonoentration 
of A1 in the activation mixture. In order to show that all 
the A1 had been used up 1n the plateau regions of the curves, 
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Figure 19. L1m1t1ng nature of P' 1n the reaction with A1 • 
P' was partially purified over P-60 as de-
scribed in Materials and Methods, section 12, 
Method IIB. P, S and A1 were prepared as de-
scribed in the text. Each point represents 
the incubation of 15 pl. of P' with 75 pl. of 
A1 1n a 125 µl. total volume for the time in-
dicated on the abcissa. At 45 minutes 75 µ1 . 
· of P 9 were added to one tube, 25 µ1. of S t o 
another and 50 µ1. of P to the third. 
-82-
5 
P' 
4 
c 
·-E 3 
0 
-
" :l E 
l{) 2 
,.._ 
v 
0 
0 
<l s p 
0 20 40 60 80 100 
TIME (min) 
~Ug-
Figure 20. A1 concentration curves. A1 and P' were pre-
pared as described in the text. 
Curve 11 each point represents 2 pl. of 
A1 incubated wi~h 40 µl. of P
1 in a total volume 
of 50 pl. for the time indicated. on the abcissa 
followed by a phenol ox1dase assay. 
Curves 2, J and 4 represent the same 
exp~riment with 5 µl., 8 µ1. and 10 pl. of A1 
per point respectively. 
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additional P' was added to curves 2 and 4 at 60 minutes. 
This had no effect on · the phenol oxidase produced. Add.i-
tional A1 added to curves 1 and 2 at JO minutes also 
caused no additional phenol oxidase production indicating 
that no P' was left in these tubes. A large excess of P' 
was added to tube 3 at 60 minutes followed by addition of 
excess A1 30 minutes later. Again no additional phenol 
oxidase was produced showing that P' activity is unstable 
in the presence of active phenol oxidase. 
4. * P 1 and Pure A1 • 
Highly purified P' (Materials and Methods, 
section 12, Method II, part D) was reacted with pure A1 , 
shown to be homogeneous by Meltzer (2). Phenol oxidase was 
produced 1n the reaction, strengthening the concept that 
the P' and A1 reaction involves only those two components. 
Activation of phenol ox1dase in crude homogenates 
results in a highly aggregated product (35). In order to 
determine if the enzyme produc~d by partially purified 
components also aggregates, the following experiment was 
performed. Active phenol oxid.ase was produced using P' 
(Materials and Methods, section 12 Method I) and pure A1 • 
The reaction mixture was layered on a 5 to 20% (w/v) 
sucrose gradient and centrifuged at 32,000 g (max.) for 16 
I 
* Prepared by Dr. Paul Meltzer. 
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hours 1n the Type SW 39 rotor. All the phenol ox1dase 
activity was found at the bottom of the tube, 1nd1cat1ng 
extensive aggregation. Unreacted A1 moved about 0.2 cm. 
into the gradient. A hemoglobin marker moved. slightly 
behind the A1 • 
• 
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DISCUSSION 
1. General. 
The existence of 6 protein components, designated 
Pre S, S, P, A1 , A2 and A3 , which participate in the acti-
vation of phenol oxid.ase in Drosophila has been described 
by Mitchell et al. (33, 34). In the work presented here 
the existence of Pre s, S and P has been confirmed and two 
additional components, S activator and pt, have been de-
scribed. The partial purification of S, P, pt and S acti-
vator has been reported and the interactions of several of 
the constituents of the activating system have been studied. 
2. Preparations of the Components. 
A. Purifications. 
In interpreting the results presented here 1t 
would be useful to know the degree of purity of the com-
ponents which have been used in the study of the activation 
process. Most of the components cannot be assayed for in 
crude homogenates so it is usually not possible to determine 
the extent of purification in the early stages of. a frac-
tionation scheme. Rough estimates however can be made. 
For instance in the case of the S component, if 100% yield 
is assumed through the ammonium sulfate fractionation a.nd 
25% yield over the hydroxylapatite column, then the S acti-
vity would be 1,500 fold purified over the total soluble 
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protein. In the case of P, 100% yield through the ammonium 
sulfate step would result in a 70 fold purification through 
the total scheme. In the case of P', 25% yield through 
ammonium sulfate fractionation results in 1,000 fold puri-
fication through the purification described. These esti-
mates are presented simply in ord.er to give some id.ea of 
the likelihood that the various components described could 
be contaminated with other unknown constituents of the 
activating system. 
B. Resolution. 
The S, P and P' components have been shown not to 
be cross contaminated with each other or with A1 by tests 
for enzymatic function. A2 and AJ were not assayed for 
directly but the fractionation data of Meltzer (2) indicate 
that S, P and P', prepared as described, should not be con-
taminated with these components. 
3. Reactions of the Components. 
A series of experiments were conducted in order to 
determine the nature and sequence of the reactions which 
are concerned with the production of phenol oxidase. An 
activation scheme which is consistent with all the data 
presented is shown. in the Introduction, Figure 1. This 
mod.el depicts the first step in the activation sequence as 
the reaction between Pre S and S activator to produce s. 
From the data presented here there is no way of conf 1rming 
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that the Pre S to S reaction is 1n fact the first step in 
the activation of phenol ox1dase. The S activator itself 
could be latent. In this case the apparent lack of S ac-
tivator in 4 to 8 hour prepupae could be due to the lack 
of a component required for activation of the S activator. · 
This hypothesis could easily be tested using mixing expe-
riments to see if extracts of other age animals could cause 
the appearance of S activator in 4 to 8 hour prepupal ex-
tracts. 
Since the first step in the activation reaction is 
likely to be the object of regulatory systems it would be 
of considerable interest to d.emonstrate the first reaction 
in the sequence unambiguously. It should be noted that an 
analysis of the data presented here on the kinetics of ac-
tivation of S would not be likely to shed any light on this 
question. The activation curve presented in Figure 11 
represents a composite of two reactions. First there is 
the production of S which will react in the H reaction to 
produce phenol oxid.ase and second there is the reaction of 
S and P, which ls also present in the crude Pre S fraction, 
to produce P' which also reacts in the H assay. As a con-
sequence no conclusions can be drawn from the shape of the 
curve regarding mechanisms of the S activation. 
The second step in the activation reaction as depicted 
in this model is the reaction of Sand P to produce P•. 
The kinetic data strongly suggest that S acts in a catalytic 
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fashion on P to produce pt. The possibility that S acts 
on another component in the P preparation which then reacts 
with P cannot be excluded until P is more highly purified. 
The apparently simple kinetics of the S and P reaction seen 
in Figures 14 and 16 and the fact that the P is approximately 
70 fold purified make it appear likely however that the 
reaction does occur as depicted. 
The third step in the activation sequence shown in 
Figure 1 is the reaction of pt with A1 to produce phenol 
oxidase. The reaction of P' with A1 has been carried out 
with highly purified components. The A1 was shown to be 
homogeneous by Meltzer (2) and. the pt has been estimated 
to be greater than 1,000 fold purified. There is not a 
strong likelihood that any other components will be shown 
to participate in this reaction. The precise nature of the 
reaction however is a matter of considerable conjecture. 
The end product of the reaction is a highly aggregated 
molecule. Two types of reaction sequence can be visualized. 
In the first case P' could act on A1 to produce an inter-
mediate, either with or without phenol oxidase activity, 
which then aggregates. In the second case P' could act 
directly on A1 to produce an aggre·gated product without the 
production of an intermediate. It is not known at this time 
. 
whether the aggregation reaction is necessary for activation 
or is a consequence of it. The instability of phenol ox1-
dase to high speed centrifugation (40) suggests the possi-
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bility that the aggregated state may be necessary for ac-
tivity. 
Another question of considerable interest concerning 
this reaction is whether pt is incorporated into the active 
enzyme. The limiting nature of pt in the reaction with A1 
suggests the possibility that pt does play a structural 
role in the phenol oxidase molecule. The limiting nature 
of pt can also be explained by its apparent instability in 
the presence of active phenol oxidase but this does not 
preclude the possibility that pt does get incorporated into 
the active enzyme. One experiment which could be expected 
to shed some light on this question would be to activate · 
A1 with pt under conditions which block phenol oxidase ac-
tivity and see whether or not pt is still limiting in the 
reaction. A d.efinitive answer to this question will have 
to await the preparation of homogeneous P'. This could 
then be labelled and it would be a simple matter to see 
whether pt gets incorporated into the active product on 
reaction with A1 • 
There is good evidence that the reactions depicted in 
this model occur and are necessary for the production of 
phenol oxidase in extracts of Drosophila. The possibility 
that other reactions occur and are necessary cannot be ex-
eluded at this time. !!! vivo A2 and A3 can also be expected. 
to participate in the activation. At present however there 
are very few data concerning the activation of these com-
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ponents. Techniques for the preparation of highly puri-
fied A2 have been worked out (2) and it should be an easy 
matter to determine if the A1 activating system also works 
on A2 • The participation of A2 and A3 in the active enzyme 
is further discussed in Section 5 below. 
It is of interest at this time to speculate on the 
reasons why such a complex activating system is required. 
This may be related to both the toxicity and function of the 
enzyme. It is necessary for the animal to maintain unneeded. 
enzyme in an inactive form due to the extreme toxicity of 
the react ion prod.ucts of the enzyme. However, the animal 
must also be able to activate large quantities of phenol 
oxidase rapidly, within a well defined temporal sequence ~ 
during periods of cuticular hardening and pigmentation . 
The amplifying characteristics of a scheme such as that 
proposed in Figure 1 allow the production of large quan-
tities of enzyme to be triggered by the release or syn-
thesis of a small amount of S activator, In the absence of 
this component the animal is protected against possible 
activation, 
4. Mechanisms of the Reactions. 
The scheme proposed in Figure 1 does not specify the 
mechanisms involved in any of the reactions. There is 
some evidence that at least one of the steps involves 
limited proteolysis. P has been shown to have a molecular 
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weight in excess of 60,000 daltons as estimated by gel 
filtration. pt has been shown to have a molecular weig~t 
of approximately J0,000 daltons, again as estimated by gel 
filtration. If the hypothesis that P' is produced from P 
is accepted, then a proteolytic mechanism appears likely. 
Alternatively, the reaction could involve dissociation of 
subunits, perhaps by reduction of disulphide linkages. 
Direct verification that the pt activity produced in the 
S and P reaction is the same as the J0,000 molecular 
weight pt purified from a 0-35% ammonium sulfate fraction, 
will involve isolating P' from a purified. S and P reaction 
mixture. 
There are no data bearing directly on the mechanism 
of activation of A1 by P'. The proenzymes of Bombyx and 
Calliphora phenol oxidases and A1 from Drosophila have 
been activated with proteolytic enzymes (20, 25, 2). In 
all three cases however, only a small fraction of the 
potential activity was released. The suggestion has been 
made that the natural activation may also involve limited 
proteolysis (20, 25). The activation by proteolytic 
enzymes has no direct bearing on the question of natural 
activation but the proteolytic activation mechanism is an 
attractive hypothesis. It should be possible to test this 
mechanism in the A1 and P' reaction by stopping the acti-
vation reaction with strong denaturing agents and searching 
for intermediates with an altered molecular weight. If the 
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aggregation reaction were to occur rapidly and produce a 
non-dissociable product, it could prove difficult to isolate 
the putative intermediate. 
As mentioned above, the question of the participation 
of pt in the aggregation reaction must also be considered 
in a discussion of the mechanism of activation of A1 • An 
alternative hypothesis to the proteolytic mechanism is that 
A1 depends on the aggregated state for activity and pt is 
required for formation of the aggregate but does not 
structurally alter the A1 molecule. The role of P' in the 
format ion of the aggregate could. be as a structural compon-
ent necessary for the stability of the aggregate. pt acting 
in this way might also catalyze the formation of covalent 
bonds in the aggregate. P' could also function in the 
formation of an aggregate by catalyzing the formation of 
covalent bonds between A1 molecules without functioning i n 
a structural role. 
5. Further Experiments. 
Further studies on the properties of the aggregated 
enzyme should be possible usi~g purified pt and A1 • 
Blumenthal's work ( 48) ind.1cates that the enzyme produced 
by activation in crude homogenates is at least partially 
covalently cross linked. The dissociability of the aggre-
gate formed in the purified system could be determined to 
see if covalent cross 11nk1ng also plays a role 
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in this system. If covalent cross linking does occur in 
the purified system it should be possible to exclude 
rigorously small molecules from the system to determine if 
small molecules are required for cross linking. If A2 and 
A3 were prepared in purified form it would be possible to 
determine the effects of variations in the proportions of 
A components on the degree of aggregation, substrate 
specificity and density of the enzyme produced. 
In light of Lewis and Lewis's demonstration of the 
participation of lipid in the activation reaction (32) and 
in view of Blumenthal's observation that banded. phenol 
oxid.ase contains lipid (48) it would be of interest to 
determine the effect of exogenous lipid on the activation 
and aggregation in a purified system. 
Another problem which should be amenable to analysis 
with purified components concerns the function of the phenol 
oxidase system. Phenol oxidase has been proposed as a 
major structural protein in the formation of cuticle as 
well as being involved in tanning and hardening of the in-
tegument. The cuticular function of phenol oxidase has 
however not been rigorously proven. It has been suggested 
by Meltzer (2) that a definitive answer to this question 
could be arrived. at by preparing labelled A1 , 1.nject 1.ng 1 t 
into the hemolymph and. observing 1f radioactivity gets 
incorporated. into the cuticle. As he points out this 
would depend on the assumption that radioactive A1 
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injected into the hemolymph could reach the site of cuticle 
synthesis. Another possibility would be to prepare labelled 
antibodies directed at A1 in an attempt to localize A1 in 
the cuticle using techniques of immunofluorescence. This 
would depend on the assumption that the antigenicity of A1 
is not too greatly altered during incorporation into the 
cuticle. The experiment might also be done by preparing 
antibodies to phenol oxidase prepared from purified compon-
ents on the assumption that such material might more closely 
resemble the material in the integument than A1 does. 
With a detailed knowledge of the activation reaction 
it should be possible to bring genetic analysis to bear on 
the phenol oxidase system. Biochemical analysis of known 
body color mutants and strains with cuticular abnormalities 
might be expected to provide information concerning the genes 
responsible for the synthesis and. regulation of phenol 
oxidase components. As an interesting example of this type 
of analysis, Mitchell (35) has shown that in the period 
from 70 hours following puparium fo·rmation to emergence, 
extracts of straw mutant flies activate considerably more 
slowly than extracts of wild type flies although the 
potential maximum activity is higher in the mutants. This 
slow period corresponds to the time in which pigmentation 
normally occurs in wild type flies. It would be of inter-
est to compare the activating system of straw flies with 
that of wild. type to see if it were possible to localize 
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the difference to a single component of the activating 
system. Mitchell has also investigated the density 
distribution of phenol oxidases from several body color 
mutants and found that density distributions were specific 
to a mutant and developmental stage (40). Further bio-
chemical analysis of these strains would also be of inter-
est. Another strain of potential interest for this type 
of analysis is the alpha strain .isolated by Lewis and 
Lewis (32). They suggest that the alpha gene affects the 
primary structure of the enzyme sinee phenol oxidase iso-
lated from this strain is more thermolabile than the wild 
type enzyme. 
6. Possible Regulatory Mechanisms. 
Through the analysis of genetic mosaics it has been 
shown that pigmentation of a given portion ot the cuticle 
is regulated by the underlying epidermal cells (49)a A 
number of mechanisms can be proposed to explain the reg-
ulation of phenol oxidase activity by these cells a Two 
main levels of regulation can be conceived of, at the 
substrate level, and at the enz;vme level. 
Concerning regulation at the substrate level, 
Mitchell (50) has pointed out that all degrees of hardness 
and pigmentation observed in cuticular structures could be 
regulated by the amount and type of substrate presented to 
the enzyme. The epidermal cells could be expected to play 
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an important role in the regulation of substrates available 
to the enzyme by controlling the pathways of substrate 
synthesis. It will be necessary to have a greater under-
standing of the pathways of phenolic metabolism before it 
will be possible to understand fUlly the potential control 
systems operating at the substrate level. 
At the enzyme level the epidermal cells can be expected 
to regulate cuticular hardening and darkening through the 
control of the amount and type of components released into 
the cuticle. Substrate specificity and the structural 
properties of the enzyme could be regulated by controlling 
the relative amounts of A components secreted into the 
cuticle. Variations 1n the amount of activating components 
can be expected to affect enzyme levels and possibly also 
the structural properties of the enzyme produced. In this 
Tegard it is likely that the first component in the acti-
vation scheme is subject to tight regulation. The proper-
ties and tissue localization of this component, possibl y 
the S activator, merit further studies and must be de-
scribed before the in vivo process of activation can be 
understood. 
In summary, it appears likely that genetic and bio-
chemical analysis of phenol oxidase will provide useful 
information concerning the regulation of cuticle b1osyn-
thes1s. 
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PART II 
STUDIES ON SERUM INSULIN IN NORMAL SUBJECTS AND DIABETICS 
-103-
INT RO DUCT ION 
1. General. 
-The relationship of pancreatic hypofunction and dia-
betes mellitus was first described by von Mering and 
Minkowski (1) in 1889. It was not until 1922 however that 
Banting and Best were able to isolate the active pancreatic 
principle (2). The isolation of crystalline insulin was 
accomplished by Abel in 1926, this being the first isolation 
of a crystalline protein with specific biological properties 
(J). In spite of the fact that insulin ·and its relationship 
to diabetes have been known for so long, several problems 
remain concerning the nature and function of the hormone 
and 1ts connection with diabetes mellitus. In particularp 
the nature of the circulating hormone and the primary 
metabolic effects associated with insulin action are poorly 
understood. In ad.d.ition, little is known concerning the 
primary molecular defects associated with diabetes. Al-
though diabetes can be described as a functional lack of 
insulin activity, the reasons for this lack are not under-
stood .• 
This thesis is concerned with an electrophoretic 
analysis of serum insulin, which was carried out to eluci-
date further the nature of the circulating hormone and to 
test the hypothesis that at least some forms of diabetes 
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may be the result of the secretion of polymorphic forms of 
insulin with altered biological properties. To provi~e a 
background for the work presented here the remainder of 
this introduction is devoted to a brief review of insulin 
biosynthesis, the nature of serum insulin and. possible 
molecular mechanisms associated with the onset of diabetes. 
No mention is made of the metabolic effects of insulin or 
of the metabolic defects associated with diabetes. These 
subjects have been extensively reviewed. elsewhere (4, 5, 6). 
2. Biosynthesis of Insulin. 
The insulin molecule consists of two chains, the A and. 
the B chains, of 21 and 30 amino acids respectively, which 
are joined. by two disulphide linkages (7). Following this 
discovery considerable speculation arose concerning the 
mechanism of its biosynthesis. The two possibilities most 
actively considered were combination of separately synthe-
sized. chains (8) and biosynthesis from a single polypeptide 
precursor (9). The validity of the second hypothesis was 
shown by Steiner and co-workers (10, 11, 12, 13). While 
studying the incorporation of labelled amino acids by an 
islet cell ad.enema prepared from a human pancreas, a 10,000 
molecular weight peptide was isolated and shown to exhibit 
a precursor product relationship with insulin. The peptid.e 
was found to be immunologically related. to insulin and was 
shown to be converted into a molecule differing from insulin 
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by only one amino acid on incubation with trypsin. Further 
studies on isolated islet cells from rat pancreas conf 1rmed 
these findings. The insulin precursor was named proinsulin 
and was shown to be a single polypeptide chain consisting of 
the A and B chains of insulin linked by a connecting peptid.e. 
Amino acid sequence data and immunological analysis of pro-
insulins from several species indicate considerable hetero-
geneity in the connecting peptide (14, 15, 16). These 
results suggest that the connecting segment may have few 
specific structural requirements. The mechanism of conver-
sion of proinsulin to insulin has not been worked out but 
an intermediate form of the molecule has been found which 
was shown to consist of proinsulin in which cleavage of a 
peptide bond had occurred to prod.uce an A chain connected 
by disulphide linkages to the rest of the peptide. 
3. Nature of Serum Insulin. 
A. General. 
Insulin has never been extracted from blood in 
quantities sufficient to permit chemical analysis. As a 
result the term serum insulin refers only to an activity 
in serum which mimics that of crystalline insulin in one 
or more of a variety of systems. A prime difficulty in 
this field is determining whether the activity being 
studied. ls in fact d.ue to pancreatfc insulin. 
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B. Assays, 
Two assays based on the biological activity of 
insulin and one based on its immuno l ogical reactivity are 
in common usage for the study of serum insulin. The bio-
assays involve either measurement of glucose uptake by the 
isolated rat hemidiaphragm or measurement of the conversion 
of glucose to co 2 by the rat epid.1dymal fat pad. The 
radio-immunoassay involves a competition reaction between 
labelled and cold insulin for binding sites on an anti-
·1nsul1n antibody. It ls described 1n more detail 1n Results, 
section 1. 
The fat pad assay almost certainly responds to substances 
in serum which are unrelated to pancreatic insulin . Onl y a 
small quantity of the insulin-like activity measured i n t h i s 
assay ls suppressed by anti-insulin antibodies and the act i -
vity persists in the serum of pancreat1zed animals (1 7). 
The activity measured. by the hemidiaphragm method, on the 
other hand, ls suppressed by anti-insulin antibod i es and i s 
absent in the serum of pancreat l zed animals (1 7). There ls 
however a serious lack of proportionality on d.1lut1on . The 
rad lo-immunoassay measures 1mmurioreact1ve 1nsul1n and ls 
independent of the biological action of the hormone. The 
validity of this assay has been evaluated (18, 32) and the 
results have been favorable. It appears likely that the 
immunoassay does not respond to substances 1n serum 
unrelated. to pancreatic insulin. The question of whether 
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the assay measures the true biological activity of serum 
insulin is more open to d.ebate. Data relevant to this 
question are discussed in parts C and D below. 
c. Circulating Proinsulin. 
Steiner et al. (19) found that proinsulin was 
present in the serum of every subject they measured. Pro-
insulin reacts in the immunoassay and was found to account 
at times for up to 50% of the immunoassayable insulin. 
Proinsulin has low biological activity (16) so this could. 
cause immunoassayable insulin levels to be falsely elevated. 
over the true biological activity. The physiological 
significance of the presence of proinsulin in serum is not 
known. 
D. Bound Insulin. 
Several investigators, using the hemidiaphragm 
assay, have provided evidence that some of the serum insulin 
is associated with a high molecular weight fr~ction of the 
serum proteins (20, 21, 22). Workers using the immunoassay 
method have been unable to confirm this observation (17, 2J). 
This discrepancy can be explained in one of two ways. The 
high molecular weight insulin-like activity could represent 
true biologically active 1nsul1n bound to a carrier protein 
and not susceptible to immunological assay or an artefactual 
activity similar to that seen in the fat pad assay. 
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Disruption of the putative insulin-carrier complex in an 
attempt to release immunoreactive insulin might be expected 
to resolve this controversy. 
E. Half-life of Serum Insulin. 
Several investigators have measured the half-life 
of insulin in human serum • . Using immunoassay techniques, 
the value for both endogenous and exogenous insulin has 
been estimated at between 9 and 16 minutes for both non-
d1abetics and d.iabetics who have never been treated with 
insulin (24, 25, 26, 2?). The half-life of the hormone in 
insulin treated diabetics has been estimated to be on the 
order of several hours (28, 29). The longer half-life is 
reported. to be due to the binding of insulin by antibodies 
present in the serum of these individuals. 
4. Possible Molecular Defects in Diabetes. 
A. General·. 
A knowledge of the precise molecular defects 
involved in the onset of diabetes would be potentially 
useful in devising methods for the diagnosis and treatment 
of the disease. It would also be useful in an analysis of 
the inheritance of the disorder. Diabetes has long been 
known to have a genetic component but the exact mode of 
inheritance is unknown. Part of the problem is undoubtably 
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due to difficulties involved in recognizing the phenotype. 
Diabetes is diagnosed through observation of disord.ers in 
carbohydrate metabolism but the observed disorders could. 
arise as the result of a number of different primary 
molecular mechanisms. If this were the case, meaningful 
genetic analysis would have to await the elucid.ation of 
these mechanisms. 
The functional lack of insulin activity in diabetes 
can be explained. by one of three general mechanisms, which 
are not mutually exclusive. First, normal insulin could be 
synthesized and its action could either be blocked by an 
antagonist or the tissues might for some reason be unable 
to respond.. Second, abnormal or polymorphic forms of insulin 
with defective biological properties could be synthesized 
and third, defects in the biosynthetic or secretory 
machinery could block the production or release of insulin. 
There are few reliable data concerning the first possibilityQ 
The second and. third hypotheses are discussed below in parts 
B and c. 
B. Polymorphic Forms of Insulin. 
Insulin polymorphism has been observed only in the 
rat which produces two forms of the hormone differing in 
amino acid sequence (JO). Each individ.ual appears to produce 
both types of molecule. Considerable heterogeneity is 
observed when insulin from most species, including humans, 
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is analyzed by oisc electrophoresis (31). This is not the 
result of ~enetic polymorphism however, but appears rather 
to be the result of progressive deamidation of the molecule, 
perhaps during isolation and purification. 
The possibility that an abnormal or polymorphic form 
of insulin might account for the symptoms of diabetes was 
actively considered. following Berson and. Yalow's demonstration 
that high levels of immunoreactive insulin are present in 
the blood of diabetics (32). They suggested that their 
results could be explained. by assuming that an abnormal 
insulin with defective biological activity but near normal 
immunological reactivity was present. This hypothesis has 
been extensively investigated by Roy and co-workers (33, 34, 
35). They demonstrated that immunoassayable insulin in t he 
serum of juvenile diabetics is more resistant to the action 
of insulinase than insulin from the serum of normal subjects. 
They were also able to show that immunoassayable insulin 
isolated from diabetic pancreases is less effective 1n 
promoting glucose uptake by the rat hemidiaphragm than is 
insulin from normal pancreases . Roy suggests that these 
results support the notion that an abnormal insulin, perhaps 
resulting from gene mutation, 1s present in diabetics. 
These results, and also those of Berson and Yalow can also 
be explained. by assuming that the abnormal insulin ls 1n 
fact proinsulin. Proinsulin reacts in the immunoassay (19) 
and has little biological activity (16). Recently Roy et al. 
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( )6) have demonstrated that insulin, isolated from diabetic 
pancreases and shown to be free of proinsulin, is less 
effective than normal insulin in stimulating uridine uptake 
by human fibroblait cultures. It is not known, however, 
how specific this assay is for insulin activity. 
Kimmel and Pollock (37) have reported a possible amino 
acid substitution in insulin isolated from a diabetic pancreas 
but the amounts analyzed were too low for reliability. 
Brunfeldt et al. (38) were unable to find any chemical 
or biological differences between insulin isolated from 19 
pooled diabetic pancreases and normal human insulin. This 
does not rule out the possibility that a portion of the 
diabetic insulin was abnormal however. 
It would appear that the question of the existence of 
polymorphic forms of insulin 1n diabetics is still an 
unsettled problem. 
C. Defects in Biosynthesis and Secretion. 
Steiner (16) has suggested that defects· in insulin 
biosynthesis could account for at least some types of 
diabetes. Mutations affecting the structure of proinsulin 
could block its conversion to insulin. Similarly, mutations 
in the enzymes responsible for the conversion of proinsulin 
to insulin could also block the synthesis of the hormone. 
These hypotheses should be amenable to experimentation but 
there are few data available at this time. 
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Impaired secretion of insulin has also been advanced as 
a possible cause of diabetes (39). Again, there are few 
reliable data cortcerning this possibility. However, the 
fact that some diabetics can be treated with sulfonylurea 
type drugs, which act by stimulating the release of insulin 
from the pancreas (40), suggests that impaired secretion 
may be a factor in at least some forms of the disease. 
5. Research Outline. 
The work presented here is concerned with further 
investigations of the possibility that abnormal or poly-
morphic forms of insulin might be present in the serum of 
diabetics. Disc electrophoresis on polyacrylamide gels was 
used for the analysis of normal and diabetic serum insulin. 
This involved the development of techniques for the part i al 
purification of serum insulin and for its detection on 
polyacrylamide gels. 
I 
I 
I 
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Materials and Methods 
1. Insulin Assay. 
Insulin was assayed by Method. C of the rad.io-immunoassay 
developed by Hales and. Randle (41). 
2. Preparation of Serum. 
* Blood. ( 10-15 ml.) was collected and allowed. to clot. 
Following clot formation, the sample was centrifuged for 
20 minutes at 10,000 r.p.m. in the SS-34 rotor of the 
Servall centrifuge. Aliquots (2 ml.) of the supernatant . 
serum were stored frozen at -20°c • 
• 
). Preparation of Serum Insulin. 
A. Bio-Gel P-30 Chromatography. 
Bio-Gel P-30 (100-200 mesh) was prepared exactly 
as recommended by the manufacturer (42) and a 3.2 x 80 cm. 
column was poured. Hemoglobin (10 mg.) was dissolved in 
4 ml. of serum and the sample was applied to the column and. 
eluted. with 0.05 M (NH4 ) 2co3 pH 9.0 at a flow rate of 28 ml. 
per hour. Fractions (4.5 ml.) were collected. Material 
eluting in the void volume, as determined by the elution of 
the hemoglobin marker, was discarded and. subsequent fractions, 
* Courtesy of Dr. s. Gord.on · Ross. 
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corresponding to 3 void volumes, were pooled. 
B. Ultrafiltration. 
In some experiments the pooled fractions were 
desalted using ultrafiltration in an Amicon apparatus. A 
UM-2 membrane was used. 
c. Lyophilization. 
The pooled fractions were lyophilized to dryness. 
The dried material was dissolved in 200 pl. of 0.01 M 
phosphate pH 6.7 for use 1n electrophoresis experiments. 
4. Disc Electrophoresis. 
Disc electrophoresis on polyacrylamide gels was carried 
out by the method of Davis (43). The concentration of 
acrylamide was 20% and the concentration of methyleneb1s-
acrylamide was 0.15%. Electrophoresis was carried out at 
2 ma per tube constant current for 30 minutes following the 
time the tracking dye reached the end of the gel. Electro-
phoresis was done at o-4°c. 
5. Gel Fractionation •. 
Polyacrylamide gels were fractionated by the method of 
Ward (44). This technique involves controlled. extrusion of 
the gel through a small orifice. Usually, 75 fractions 
were obtained from a 6 cm. gel. Each fraction was incubated 
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0 
at 0 c. in 250 µl. of 0.01 M phosphate pH 6.7 for 24 hours 
following which 100 µl. aliquots were withdrawn for the 
assay of insulin. 
6. Measurement of Radioactivity. 
Radioactivity was determined in a Nuclear Chicago 
model 7-24 liquid scintillation counter. The scintillation 
fluid consisted of ethanol (150 ml.), dioxane (JOO ml.), 
napthalene (50 g.), 2,5-diphenyloxazole (5 g.) and. toluene 
to 1 liter. In general, 10,000 counts were obtained for 
each sample. 
7. Reagents. 
All reagents were reagent grade. Antibodies and 
iodinated insulin for use in the radio-immunoassay were 
obtained from Amersham-Searle corporation. Hemogl ob1n e 
bovine crystalline insulin , and bovine albumin powder we r e 
obtained from the Sigma Chemical Company . 
I 
I 
I 
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RESULTS 
Section 1. Assay. 
A. General. 
The assay of insulin in concentrations comparable 
to those found in human serum requires very sensitive 
techniques. The two main types of assay which are suitable 
for this purpose are bioassays and radio-immunoassays. Bio-
assays generally involve the measurement of a biological 
effect of insulin on isolated tissue. Radio-immunoassay 
techniques depend solely on the immunological reactivity 
of the insulin. A radio-immunoassay was used in the 
experiments reported. here since a primary objective of 
these experiments was the detection, in diabetic serum, of 
altered insulin molecules with defective biological prop-
erties. These would not be expected to react in a bioassay 
but it was hoped that immunological cross reactivity would 
remain. 
The radio-immunoassay depends on a competition reaction 
between a constant concentration of labelled insulin and 
variable concentrations of the unknown for binding sites 
on anti-insulin antibodies. The amount of radioactivity 
bound ls inversely proportional to the insulin concentration 
of the unknown. Different assays vary in the techniques 
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used to separate the bound. and unbound insulin in the 
incubation mixture. In the assay of Hales and Randle (41) 
which was used in these experiments, the separation is 
obtained by membrane filtration. The insulin-antibody 
complex is retained while the unbound insulin passes 
through. The filter discs can then be counted directly to 
determine the amount of labelled insulin bound in the 
competition reaction, 
B. Standard Curve. 
A standard curve for the Hales and Randle assay 
is Shown in Figure 1. The reciprocal of the bound radio-
activity is plotted against insulin concentration. The 
assay is linear at low concentrations and 1s sensitive to 
changes in insulin levels over a 40 fold range. The linear 
portion of the assay corresponds to insulin concentrations 
normally found in human serum. 
The assay was to be used for the determination of 
insulin eluted from polyacrylamide gels. Experiments were 
conducted. to determine if polyacrylamide gel fractions or 
exogenous proteins had any effect on the standard curve. 
No effects were observed, 
Section 2. Preparation of Insulin From Human Serum. 
Due to the low concentrations of insulin found in 
serum it was not possible to electrophorese serum samples 
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Figure 1. Stand.ard curve for the insulin assay. Bovine 
crystalline insulin was used as a standard. 
Dilutions were prepared and. assayed as described 
in Materials and. Methods. 
-119-
• 
1000 
900 
800 
(.0 700 
0 
x 600 
-I 
::? 500 
a.. 
u 
400 
300 
200 
100 
2 4 6 8 I 0 12 14 16 18 20 
INSULIN CONCENTRATION I0-9g/m i 
( 
I 
i 
I 
-120-
directly. A partial purification and concentration of the 
insulin activity was required. Because of the low molecular 
weight of insulin as compared to the bulk of serum proteins, 
this was easily accomplished by gel filtration on Bio-Gel 
P-30 as described in Materials and Methods, section 3. In 
order to allow concentration of the insulin-containing 
fractions by lyophilization, the column was eluted with a 
volatile buffer, 0.05 M (NH4 ) 2co3 • In this way it was 
found . possible to prepare the insulin from 4 ml. of serum 
in a volume of 200 µl. with protein concentrations low 
enough to allow electrophoresis of the sample. 
·section 3, Electrophoretic Analysis of Serum Insulin. 
A. Normal Human Serum. 
Experiments involving electrophoresis of insul i n 
from normal serum were conducted in an attempt to determine 
the normal electrophoret1c pattern of serum insulin . 
Insulin, prepared from 2 ml. of human serum (Materials and 
Methods, section J), was electrophoresed on a 20% acryl amide 
gel and the gel ·was fractionated as described in Materials 
and Methods, section 5, Aliquots of the fractions were 
assayed for 1nsul1n activity (Materials and Methods, section 
1). The results of a typical experiment are shown in 
Figure 2. A major peak of immunoreactlve insulin was 
observed, preceded. by a cluster of more rapidly moving 
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Figure 2. Electrophoresis of normal insulin. An aliquot 
(100 pl.) of normal insulin (Materials and 
Methods, section J) was electrophoresed on a 
6 cm, 20.% acrylamide gel, Fractions (75} were 
collected and assayed for insulin activity. 
Relative insulin concentration refers to the 
reciprocal of the counts per minute obtained i n 
the assay times 106 • The direction of migrat i on 
is indicated by the arrow. 
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• minor peaks. The faster moving peaks were always seen to 
be present in repeat experiments and were sometimes 
resolved into two or three components. An attempt was made 
to determine if the faster moving components were being 
ge.nerated from the major peak under the conditions of the 
experiment. An aliquot from the peak tube of activity in 
an experiment such as that depicted in Figure 2 was incubated 
for 24 hours in 0.05 M (NH4 ) 2co3 and. re-electrophoresed on 
a 20% acrylamide gel. Fractions were taken and assayed for 
insulin activity. The results of this experiment are 
depicted in Figure ). In this case no evidence of faster 
moving peaks was observed. It is possible that a small 
amount of the faster moving material could have been 
generated during this proced.ure and. not have been detected. 
in the assay but it doesn't appear that significant conver-
sion occurred. 
B. Diabetic Serum. 
Experiments were conducted in an attempt to 
determine if electrophoretic abnormalities could be detected 
in the insulin isolated from the serum of diabetics. Insulin 
was prepared from the serum of 12 diabetic patients, 5 of 
whom were receiving insulin therapy. In agreement with the 
results of Berson and Yalow (32), serum levels ~f the 
· / hormone in all or the diabetics were comparable to or higher 
than those found in normal subjects, Insulin from each or 
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P1gure 3. Re-electrophoresis of normal insulin. An aliquot 
(100 µl.), obtained from the peak tube of an 
experiment such as that described. 1n Figure 2, 
was electrophoresed on a 6 cm., 20% acrylam1de 
gel. Fractions (75) were collected and assayed 
for insulin activity. The direction of migration 
is indicated by the arrowo 
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the diabetics was mixed. with normal human insulin and 
electrophoresed. Gels were fractionated and assayed for 
insulin activ1ty as described in Materials and Methods. In 
the case of 10 of the diabetics, no differences could be 
detected between the electrophoretic pattern of the mixture 
and that of the normal insulin alone. In the case of two 
diabetics, designated GA and GWII, who had been receiving 
insulin therapy, the electrophoretic pattern of the mixture 
differed markedly from that observed with normal insulin. 
In both cases, the pattern observed was very similar. The 
results of a mixing experiment with insulin isolated from 
GA are presented in Figure 4. This pattern was observed 
in seven repeat experiments. In no ease was a normal pattern 
observed with mixtures of insulin from GA and a normal 
subject. These results could be caused by the mixing of 
two samples with slightly different electrophoretic 
mobilities. The A and B peaks could be the two main insulin 
peaks. The C peak would. then be part of the fast moving 
· material associated. with peak A. An electrophoret1c analysis 
of the insulin isolated from GA alone is shown tn Figure 5. 
This pattern does not seem to differ significantly from 
that observed with normal insulin. A peak similar in 
position to the small peak A observed. trailing the main 
fraction was occasionally observed. in analyses of normal 
insulin. 
Several attempts were made to obtain a better resolution 
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Figure 4. Electrophoresis of mixed d.iabetic and normal 
insulin. Aliquots (100 µl.) of insulin prepared 
from normal serum and diabetic serum (GA) were 
mixed and electrophoresed on a 6 cm., 20% 
acrylamide gel. Fractions (75) were collected 
and assayed for insulin activity. The direction 
of migration is indicated by the arrowe 
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Figure 5. Electrophoresis of d1abet1c insulin. An aliquot 
(100 µl.) of insulin prepared from the serum of 
the diabetic, GA, was electrophoresed on a 6 cm.j 
20% acrylamide gel. Fractions (75) were taken 
and assayed for insulin activity. 
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of the main peaks of normal insulin and that isolated from 
GA. These included isolation of insulin from peak tubes 
of separately run GA and normal insulin followed by mixing 
and re-electrophoresis. Difficulties in handling the very 
low concentrations of insulin involved precluded the 
obtaining of reproducible results. An attempt was made to 
cast 12 cm. gels of 20% polyacrylamide in the hope that the 
increased length would allow better resolution. It was 
found that gels over 6 or 7 cm. invariably broke when 
polymerization occurred. Alterations in the temperature 
of polymerization or concentrations of TEMED, BIS, and 
ammonium persulfate failed to solve the problem. Attempts 
to cast the gel in sections were also unsuccessful. Ge l s 
formed from 10% acrylamide could be cast 1n long tubes but 
failed to provide the necessary resolution. 
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DISCt!SSION 
1. General. 
It has proved possible to measure the electrophoretic 
mobility of serum insulin accurately on analytical poly-
acrylamid.e gels. The electrophoretic patterns of normal 
and diabetic insulin have been analyzed and. an indication 
that differances may occur has been noted.. 
2. Electrophoretic Pattern of Normal Insulin. 
The electrophoretic pattern of normal insulin was 
found. to be very similar to that observed on electrophoresis 
of human crystalline insulin (45}. When crystalline human 
insulin is electrophoresed, a single major protein band. i s 
observed, preceded by two less intensely staining minor 
bands. One or two very faint bands are also observed. 
trailing the major band. It has been suggested that the 
minor bands represent desamido forms of insulin produced. 
during the purification procedure (31}. The evidence 
presented here suggests that these minor forms of insulin 
I 
are also present in the circulation. The potential 
physiological significance of this observation is not known. 
J. Electrophoretic Patterns of Diabetic Insulin. 
Insulin from the serum of d.1abet1cs was analyzed in an 
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attempt to locate electrophoretic variants. The data 
presented in Figure 4 suggest a difference between the 
electrophoretic mobilities of normal and diabetic insulin. 
The patterns of normal insulin and that from the diabetic 
GA are very similar but on mixing a complex pattern is 
observed suggesting a difference in electrophoret1c 
mob111ties. A major objection to this observation is the 
lack of resolution involved. The slow moving peak A 1n 
Figure 4 is resolved by only one po1nt. Further resolution 
will be necessary before the existence of an electrophoret1c 
variant in this serum can be confirmed. As indicated, 
efforts in this regard have been unsuccessful so far. A 
more serious objection concerns the fact that the subject 
was receiving insulin therapy and the possibility that the 
altered. form of insulin represents exogenously administered 
.hormone must be considered. Evidence that this is not the 
case comes from analysis of diabetics who had received 
comparable amounts of the same type of insulin and whose 
electrophoretic patterns were indistinguishable from normal 
insulin. Unambiguous demonstration that an electrophoret1c 
variant exists will have to come from individuals who have 
not received insulin therapy~ 
If it 1s possible to demonstrate that such a variant 
exists, then genetic analysis using the altered form as a 
phenotypio marker would be expected to provide useful 
information concerning the mode of inheritance of the disease. 
-134-
Such 1nformat1on could be of great value 1n genetic 
counselling and related fields. 
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L..1.§1. Qf. Abbreviations 
(Parts I and II) 
BIS ••••••••••••• N,N'-methyleneb1sacrylamide 
TEMED ••••••••••• N,N,N',N'-tetramethylethylenediamine 
OD•••••••••••••• optical density 
CPM ••••••••••••• counts per minute 
